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Abstract
Olfaction appears to be mediated by a large family of odorant receptors (ORs) that
accounts for ∼ 1% of the human genome [1–4]. The functional characterization of
these receptors has so far been hindered by their poor functional expression in the
plasma membrane of heterologous cells.
In order to investigate the problem of inefficient OR membrane targeting,
sequential stages in the life cycle of the human OR17-40 were monitored. The
modification of the receptor by different tags enabled the direct visualization of
its biogenesis and trafficking in HEK293 cells. A multi-color labelling approach,
which involved fluorescent subcellular markers as well as the spectral separation
of membrane-inserted and intracellularly located receptors, indicated that high
over-expression led to the accumulation of the receptor in the ER, whereas low
expression levels improved its membrane targeting. To increase the efficiency of
OR-mediated signalling, fluorescence-activated cell sorting of a functional OR17-
40 - GFP fusion protein was used to separate low from high expressing cells,
thus increasing the fraction of odorant-responsive cells up to 80% of the total cell
population.
Selectively labelled cell surface receptors accumulated over time in intracel-
lular compartments, indicating constitutive receptor internalization. This process,
which was independent of receptor activation, occurred along the clathrin-mediated
pathway. Moreover, the imaging of single receptors in the plasma membrane indi-
cated that, in absence of ligand, part of the receptors are already confined within
small domains of 195 ± 10 nm. This fraction, which increased upon agonist or
antagonist binding, probably corresponds to receptors located in clathrin-coated
pre-pits.
Odorant molecules structurally related to the cognate agonist helional were
tested for their ability to activate OR17-40. It was found that an aldehyde group
connected to an aromatic ring via a carbon chain of defined length and containing
a methyl group in alpha or beta position is necessary for activating the receptor.
In addition, first evidence for an OR17-40-specific antagonism was provided.
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Finally, OR17-40 activation was monitored in cell-derived native vesicles,
opening new ways for assay miniaturization and the development of odorant screen-
ings in a micro-array format.
Version Abre´ge´e
Les odeurs seraient transmises au cerveau par une vaste famille de re´cepteurs olfac-
tifs (ORs) repre´sentant environ 1% du ge´nome humain [1–4]. La caracte´risation de
ces re´cepteurs a e´te´ jusqu’ici retarde´e par le faible taux d’expres-sion fonctionnelle
dans la membrane plasmique de cellules he´te´rologues.
Dans le but d’e´tudier le proble`me du mauvais transport des re´cepteurs olfac-
tifs a` la membrane plasmique, diffe´rentes e´tapes dans la vie du re´cepteur olfactif
humain OR17-40 ont e´te´ suivies. La modification du re´cepteur par l’addition de
diffe´rents peptides ont permis de visualiser directement sa bioge´ne`-se et son adres-
sage a` la membrane dans des cellules HEK293. Un marquage multicolore com-
prenant des marqueurs cellulaires fluorescents ainsi que la se´paration spectrale des
re´cepteurs inse´re´s dans la membrane et des re´cepteurs situe´s dans le cytoplasme
a indique´ qu’une haute sur-expression conduit a` l’accumulation du re´cepteur dans
le re´ticulum endoplasmique, alors que le transport du re´cepteur a` la membrane
plasmique est meilleur dans les cellules a` faible taux d’expression. Pour renforcer
le signal induit par le re´cepteur, le tri de cellules en fluorescence exploitant une
chime`re fonctionelle OR17-40 - GFP a e´te´ utilise´ pour se´parer les cellules a` faible
taux d’expression des cellules a` haute sur-expression, ce qui a permis d’enrichir la
fraction des cellules re´pondant au ligand jusqu’a` 80% de la population totale.
Il est montre´ que les re´cepteurs se trouvant a` la membrane plasmique et qui
ont e´te´ marque´s spe´cifiquement s’accumulent au cours du temps dans des com-
partiments intracellulaires, indiquant l’internalisation constitutive du re´cepteur.
Ce processus, qui est inde´pendant de l’activation du re´cepteur, a lieu par la voie
me´die´e par la clathrine. De plus, l’e´tude de la diffusion de re´cepteurs uniques
dans la membrane plasmique a indique´ qu’en absence de ligand, une partie des
re´cepteurs est confine´e a` l’inte´rieur de domaines de 195 ± 10 nm, qui correspon-
dent probablement a` des pre´curseurs de puits recouverts de clathrine, et que cette
fraction augmente apre`s l’addition d’un agoniste ou d’un antagoniste.
Des mole´cules odorantes structurellement similaires a` l’agoniste helional ont
e´te´ teste´es pour leur capacite´ a` activer OR17-40. Il est montre´ qu’un groupe
v
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aldehyde relie´ a` un cycle aromatique par une chaˆıne carbonique de longueur de´finie
et contenant un groupe me´thyle en position alpha ou beta est ne´cessaire pour
activer le re´cepteur. De plus, un premier exemple d’antagonis-me spe´cifique a`
OR17-40 est fourni.
Finalement, l’activation d’OR17-40 a e´te´ observe´e dans des ve´sicules natives
produites a` partir de cellules, ouvrant la voie a` la miniaturisation de tests pour le
screening de mole´cules odorantes.
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Chapter 1
General Introduction
The sense of smell is essential for the survival of most animals. It enables the iden-
tification and evaluation of food, territories, predators and reproductive partners
by detecting molecules of immense chemical variety, ranging from acids, alcohols,
aldehydes, esters, to aromatic and heterocyclic molecules. The vast capacity of
chemical recognition is thought to be based on a large family of olfactory recep-
tors (ORs) comprising up to thousand different subtypes [1–6]. These receptors are
predicted to be heptahelical transmembrane proteins, which initiate the chemoelec-
trical transduction of odorant signals via G protein-coupled cascades in olfactory
sensory neurons (OSNs) [1].
1.1 The Olfactory System
In most animals, two different olfactory systems have been developed: the main
and the accessory olfactory systems [6, 7]. The common or main olfactory system
enables the sensing of the environment, involved for example in food and prey
detection, and is remarkable for its breadth and discriminatory capacity. The ac-
cessory olfactory system, called the vomeronasal system, is involved in the mating
of a partner. It is highly specialized in recognizing pheromones, species-specific
molecules produced by one sex and perceived by the other, and gives information
on the geographic location of the mate and its reproductive state [6, 7].
In both olfactory systems, sensing is initiated by the binding of molecules to
receptors encoded by a multigene family. Odors, typically small volatile molecules
carried by the respiratory air stream, bind to ORs located in the cilia of olfactory
sensory neurons in the nasal epithelium (Figure 1.1) [7–9]. These neurons are
bipolar, with a single, unbranched axon projecting to the olfactory bulb and a
short dendrite advancing into the nasal cavity [3, 7]. In the human nose, there
1
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are more than five million olfactory neurons that are regenerated all three to six
months [10], as toxic molecules reaching the nose lead to cell death.
In OSNs, ORs are mostly concentrated at the cell surface membrane of the
cilia at the tip of the dendrite, where the sensory transduction takes place [8].
They are also present at axon terminals, where they are thought to play a role
in the guidance of developing olfactory axons [11]. Indeed, in the olfactory bulb,
the axons of OSNs expressing the same OR converge to a single ”target” called
a glomerulus [5, 12]. Glomeruli are spherical conglomerates of neuropil, which
measure about 50 to 100 µm in diameter and which consist of the incoming axons
of OSNs and the dendrites of the main projection cell in the bulb, the mitral
cell [7]. From there, the signals are transmitted to the primary olfactory cortex
and forwarded both to higher cortical areas, where the conscious perception of
odors takes place, and to the limbic system, where emotions are created [3, 5]
(Figure 1.1).
cortex
limbic 
system
OB
OE
odor
particles
odor
signals
OSNs
cilia
odor
molecules
n
e
rv
e
fi
b
e
rs
Figure 1.1: The olfactory system. Olfactory sensory neurons (OSNs) in the
olfactory epithelium (OE) detect odorant molecules carried by the respiratory air
stream. The olfactory signals are then transmitted to high brain centers via the
main olfactory bulb (OB).
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1.2 Odorant Receptors
1.2.1 Odorant Receptor Genes
ORs are encoded by the largest gene family, accounting for about 1% of the human
genome [5, 7, 8]. They have no introns in their coding sequence, which facilitates
their identification from genomic DNA [9]. In human, about 900 OR genes were
identified, but two-third of these turned out to be non-functional or ”pseudogenes”,
due to frameshifts, internal deletions or incomplete coding regions, leaving 347 pu-
tative functional ORs [13]. The large number of human pseudogenes, as compared
to about 20% in rodents [4], suggests that olfaction became less important in the
course of higher primate evolution [9].
ORs can bind either water-soluble or airborne ligands. Accordingly, their
corresponding genes can be divided into two classes: Class I genes code for ORs
binding water-soluble odorants, and Class II genes for ORs recognizing airborne
ligands [9]. Class I genes are similar to fish OR genes, whereas Class II genes are
unique to terrestrial vertebrates [4].
Human OR genes are located on almost all chromosomes, and are typically
organized in clusters of ten or more members, but are randomly located inside
one cluster [9, 14]. Transcriptional orientation can be either way, and intergenic
distances are variable [14].
1.2.2 Structural Features of Odorant Receptors
ORs display the characteristic structural features of G protein-coupled receptors
(GPCRs), such as seven α-helical transmembrane domains connected by intracel-
lular and extracellular loops of different lengths, and various conserved short se-
quences [7]. They belong to the family A of GPCRs, which includes most GPCRs,
such as rhodopsin and catecholamine receptors [3]. Family A GPCRs share two
cysteines in the first and second extracellular loops that form a disulfide bridge,
and an Asp-Arg-Tyr sequence (DRY motif) in the second intracellular loop [3,15].
However, a putative palmitoylation site, which is typical for family A GPCRs and
should allow the formation of a fourth cytoplasmic loop [15], is lacking in most
ORs [3]. There are other characteristics specific to ORs, such as an unusually long
second extracellular loop, an extra pair of conserved cysteines in that loop, and
additional short conserved sequences [6].
Within the OR family, there is a range of similarity from less than 40%
to over 90% identity, which allows the classification of OR sequences in different
subfamilies [13]. In the third, fourth and fifth transmembrane regions, the se-
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quences are very variable (Figure 1.2). In three-dimensional models of family A
GPCRs, such as adrenergic receptors [16] or rhodopsin [17], these three α-helices
are thought to form a pocket corresponding to the ligand binding site [18]. The
variability observed among ORs in this region provides the first molecular basis for
understanding the diversity and the large number of odorants that can be detected
and discriminated [7].
amino acid variability
highly conserved highly variable
Figure 1.2: Seven-transmembrane domain structure of an OR. The extra-
and intracellular ends are relatively short. The degree of amino acid conservation
in the consensus sequence is represented as a color in the rainbow spectrum, with
blue being highly conserved and red highly variable (taken from [4]).
1.3 Olfactory Signalling Pathways
1.3.1 GPCR Signalling
As all other GPCRs, odorant receptors activate a G protein upon agonist binding.
The G protein is a heterotrimeric protein comprising the subunits α, β, and γ. The
Gα subunit complexes the nucleotide guanosine diphosphate (GDP) in its inactive
state and guanosine triphosphate (GTP) when it is activated [19]. The GTP-
complexed Gα dissociates from the Gβγ subunit, which is then activated. Both
Gα and Gβγ interact with downstream effectors, leading to a cellular response
[19]. G protein activation is terminated by GTP hydrolysis on the Gα subunit,
followed by the reunification of the heterotrimeric G protein. GTP hydrolysis
is often accelerated by other proteins called regulators of G protein signalling
(RGS) [20,21].
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The Extended Ternary Complex Model — In the earliest model for GPCR
activation, the ternary complex model, receptor, ligand and G protein form a
complex leading to the activation of the G protein (Figure 1.3A). However, studies
based on constitutively active mutants of the β-adrenergic receptor led to a revised
model for GPCR activation, called the extended ternary complex model (Figure
1.3B) [22]. In this model, the receptor exists in a equilibrium between an inactive
(R) and an active (R∗) conformation. Only R∗ can interact with the G protein,
but both R and R∗ can bind ligands.
L+R+G
L+R  G
L  R+G
L  R  G
L+R+G
L+R*+G
L  R+G
L  R*+G
L+R*  G L  R*  G
A B
Figure 1.3: Models for GPCR activation. (A) Ternary complex model. (B)
Extended ternary complex model, which includes an activated receptor state R∗. R,
receptor; L, ligand; G, G protein (taken from [22]).
Ligands can be divided into full, partial and inverse agonists, as well as antag-
onists [23]. Full agonists have a preference for the R∗ state, so that their binding
shifts the R À R∗ equilibrium to the right, increasing the amount of active G
proteins. They elicit the maximal response upon binding to the receptor, whereas
partial agonists, which also prefer R∗ over R, do not fully shift the equilibrium and
only evoke a partial response. Inverse agonists have a higher affinity for R and
shift the equilibrium towards R, thus lowering the basal activity of the receptors.
Antagonists exclude the binding of agonists by binding to both R and R∗, without
changing the conformational equilibrium of the receptor.
Signal Transduction Pathways — G proteins act as transducing units and
transmit the signal from the activated receptor to the effector. The α- as well as
the βγ-subunits can interact with different effectors and thereby activate different
signalling pathways (Table 1.1).
The two most important G protein-coupled signalling pathways are the cAMP
signalling pathway and the DAG/IP3 signalling pathway.
The cAMP signalling pathway The cAMP signalling pathway uses cyclic
adenosine monophosphate (cAMP) as a second messenger. cAMP is synthesized
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Subunit Family Main subtypes Primary effector
α αs Gαs, Gαolf Adenylate cyclase ↑
αi/o Gαi1, Gαi2, Gαi2 Adenylate cyclase ↓
GαoA, GαoB K
+ channels ↑
Gαt1, Gαt2 Ca
2+ channels ↓
Gαz Cyclic GMP phosphodiesterase ↑
αq Gαq, Gα11, Gα14, Phospholipase C ↑
Gα15, Gα16
α12 Gα12, Gα13 ?
β β1-5 (6?) Different assemblies Adenylate cyclase ↑/↓
of β- and γ-subunits Phsopholipase ↑
Phosphatidylinositol 3-kinase ↑
γ γ1-11 (12?) Protein kinase C ↑
Protein kinase D ↑
GPCR kinases ↑
Ca2+, K+ (and Na+) channels
Table 1.1: Heterotrimeric G proteins and their effectors. The arrows
indicate up- or down-regulation of the effector (taken from [19]).
from the intracellular ATP by a plasma membrane-bound enzyme, the adenylyl
cyclase, and is rapidly and continuously degraded by cAMP phosphodiesterases
[24].
There are at least 8 isoforms of mammalian adenylyl cyclases, most of which
are regulated by both G proteins and calcium [24]. GPCRs acting through the
cAMP pathway can either stimulate an adenylyl cyclase via a stimulatory G protein
(Gαs or Gαolf), or inhibit it via an inhibitory G protein (Gαi). The adenylyl cyclase
can also be stimulated or inhibited by the βγ-subunit of the G protein (Table 1.1).
Both Gαs and Gαi are sensitive to two bacterial toxins, Cholera toxin and Pertussis
toxin [25, 26].
The stimulation of the adenylyl cyclase leads to a rapid increase of the cAMP
level in the cytosol and activates protein kinase A, which in turn phosphorylates
a variety of proteins.
The DAG/IP3 signalling pathway The other main signalling pathway uses
both diacylglycerol (DAG) and inositol-triphosphate (IP3) as second messengers.
GPCRs acting through this pathway are coupled to G proteins of the Gαq/11 family,
which activate the plasma membrane enzyme phospholipase C type β (PLCβ) [27].
PLCβ cleaves the lipid phosphatidyl-inositol-4,5-bisphosphate (PIP2) into DAG
and IP3. IP3 directly binds to calcium channels in the endoplasmic reticulum,
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leading to a fast increase in the cytosolic concentration of calcium. DAG activates
the protein kinase C (PKC), which phosphorylates many proteins. The DAG/IP3
signalling pathway is illustrated in Figure 1.4.
Figure 1.4: The DAG/IP3 signalling pathway. Upon activation of the re-
ceptor (R), the heterotrimeric G protein dissociates and interacts with a phos-
pholipase C β (PLC), which cleaves the lipid phosphatidyl-inositol-4,5-biphosphate
(PIP2) into diacylglycerol (DAG) and inositol-triphosphate (IP3). IP3 opens cal-
cium channels in the endoplasmic reticulum (ER), leading to an increase in the
intracellular calcium ion concentration.
1.3.2 Odorant Receptor Activation
Once an odorant receptor has bound an agonist, a cascade of events is initiated
inside the neuron, transforming the signal of ligand binding into a change in the
membrane potential (Figure 1.5) [7, 9, 28].
The ligand-bound receptor activates a G protein (an olfactory-specific sub-
type, Golf), which in turn activates an adenylyl cyclase type III (ACIII) [9]. The
cyclase converts ATP into cyclic AMP (cAMP), that binds to a cyclic nucleotide-
gated (CNG) ion channel. The channel opens and conducts cations such as Na+
and Ca2+ [4,29]. If enough channels are open for a sufficient time, an action poten-
tial is generated and propagated along the axon [7]. The membrane depolarization
is also increased by an eﬄux of chloride ions: Calcium ions entering the cell via
the CNG channels activate another type of ion channel, the chloride permeable
ion channels. This enables OSNs to amplify the signal initiated by the odorant
binding [29].
Studies on genetically modified mice in which Golf, ACIII or the CNG channel
have been deleted ( [30–32]) indicate that the cAMP pathway is the common
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Figure 1.5: Schematic view of the cyclic nucleotide transduction path-
way in OSNs. Within the cilia of the OSNs a cascade of enzymatic activity trans-
duces the binding of an odorant molecule to a receptor into an electrical signal that
can be transmitted to the brain. OR, odorant receptor; AC, adenylyl cyclase; CNG
channel, cyclic nucleotide-gated channel; PDE, phosphodiesterase; PKA, protein
kinase A; ORK, olfactory receptor kinase; α, β, γ, G protein subunits (modified
from [4]). (A) Resting state of the receptor. (B) Receptor activation.
pathway for all OSNs. Whether IP3 or other second messengers have modulatory
roles remains to be proven [7, 33].
In invertebrates, which can have both excitatory and inhibitory responses to
odors, olfaction seems to be mediated by several pathways [34,35]. In lobsters, the
main pathway seems to involve inositol phosphates [36] and in Drosophila and the
moth, there is also strong evidence for IP3 as a second messenger [37]. The final
target of this cascade, the analogue of the CNG channel in vertebrates, remains to
be identified.
1.4 Down-Regulation of OR Activation
1.4.1 GPCR endocytosis
GPCR endocytosis regulates receptor signalling by controlling the amount of re-
ceptors and ligands on the cell surface and extracellular medium [38]. The usual
process of GPCR endocytosis, called ”homologous desensitization”, involves the
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phosphorylation of activated receptors by a specific family of G protein-coupled
receptor kinases (GRKs), followed by the interaction of phosphorylated receptors
with cytoplasmic proteins called arrestins [39]. Four isoforms of arrestins have been
identified, but only two isoforms, β-arrestin 1 (β-arr1) and β-arrestin 2 (β-arr2),
are ubiquitously expressed in mammalian cells [39]. Arrestin-bound receptors are
unable to couple to heterotrimeric G proteins, disrupting the pathway of GPCR-
mediated signal transduction at the earliest stage. Moreover, binding of β-arrestins
targets many, although not necessarily all, GPCRs to the clathrin-mediated path-
way of endocytosis by interacting directly with clathrin and the adaptor protein
AP-2, two components of the endocytic machinery involved in the formation of
clathrin-coated pits [39–41].
Clathrin-Dependent Endocytosis — Clathrin-dependent endocytosis occurs
at specific sites on the plasma membrane after the formation of a complex structure,
called a coated pit, which concentrates surface proteins for internalization [42]. The
clathrin-coated pits contain two major structural proteins, clathrin and the adaptor
protein AP-2, as well as several other proteins. Coated-pit formation is thought
to be initiated by the binding of AP-2 molecules to a docking site or receptor in
the plasma membrane, followed by clathrin assembly [39, 42]. The formed pits
progressively invaginate and are finally released into the cytosol as free clathrin-
coated vesicles (Figure 1.6), a process which requires the GTPase dynamin [43]. In
the cytosol, the vesicles fuse with endosomes where the ligand is separated from the
receptor and the receptor is dephosphorylated. Receptors are then either recycled
to the plasma membrane, or degraded in lysosomes [44].
GPCRs are divided into two classes based on their affinities for β-arrestins
[45]. Class A receptors, such as β2-adrenergic receptor, known to recycle and
resensitize rapidly, preferentially bind to β-arrestin 2 and form low-affinity com-
plexes, which dissociate upon internalization of the receptor. In contrast, class
B receptors, such as angiotensin II type 1a and vasopressin 2 receptors, which
recycle and resensitize slowly, possess similar affinities for both β-arrestins and
form high-affinity complexes leading to the internalization of a stable receptor-β-
arrestin complex. Clusters of phosphorylated residues in the receptor C-terminal
part seem to be responsible for the ability of class B receptors to bind β-arrestins
with very high affinity [46]. Such clusters are absent from the C-terminus of class
A receptors [46].
Clathrin-Independent Endocytosis — The internalization of some GPCRs,
such as the the angiotensin II type 1a receptor [47], the M2 muscarinic acetylcholine
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Figure 1.6: Model for GPCR desensitization and internalization. GPCR
activation leads to GRK-dependent phosphorylation of the receptor, which facili-
tates the binding of β-arrestins. β-arrestins, via their association with the adaptor
protein AP-2, target GPCRs to clathrin-coated pits. GPCRs are subsequently inter-
nalized in clathrin-coated vesicles and are either recycled back to the plasma mem-
brane after dephosphorylation or are targeted to lysosomes for degradation. GRK,
G protein-coupled receptor kinase; P, phosphate group; βarr, β-arrestin; AP2, AP-
2 heterotetrameric adaptor complex; cla, clathrin; GRP, G protein-coupled receptor
phosphatase.
receptor [48] or D1 and D2 dopamine receptors [49], does not require β-arrestin or
dynamin. This indicates that some GPCRs follow alternative endocytic pathways,
which are still not fully characterized [39].
Clathrin-independent pathways may be mediated through lipid rafts or through
caveolae [50,51]. Lipid rafts are dynamic, detergent-resistant regions of the plasma
membrane which are enriched in cholesterol, glycosphingolipids and glycosylphos-
phatidylinositol (GPI)-anchored proteins, while caveolae are small flask-shaped
plas-
ma membrane invaginations which contain the same lipid components as rafts
as well as caveolin [50, 52]. Several GPCRs have been shown to signal in lipid
rafts/caveolae [53–55]. Moreover, several chemokine receptors, which are also
internalized via clathrin-independent pathways, have been found in raft mem-
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branes [51]. The mechanism by which caveolae or lipid rafts mediate receptor
endocytosis is not known [50], but once internalized, GPCRs enter a compartment
called the caveosome and fuse with early endosomes, which are also a component
of the clathrin-mediated pathway [51].
1.4.2 OR-Specific Inhibition of Signalling
OSNs developed many different negative feedback systems to terminate their re-
sponse to an odorant, a process which is important in order to respond to new lig-
ands. During odor responses, the rise of intracellular Ca2+ concentration decreases
the sensitivity of cyclic nucleotide-gated ion channels to cAMP [7, 9], leading to
their inactivation. Regulators of G-protein signalling (RGS) decrease adenylyl cy-
clase activity [7]. Moreover, cAMP activates protein kinase A (PKA), which leads
to the phosphorylation of serine and threonine residues of ORs [9], promoting their
internalization. Odorant-induced desensitization was also shown to be mediated
by G protein-coupled receptor kinase 3 (GRK3) [56, 57] and by β-arrestin-2 [58],
which are enriched in the dendritic knobs and cilia of the OSNs [58].
1.5 Odor Coding
Several findings indicate that each OSN expresses only one OR gene in mammals
[59–62], although an exception was found for a specific pair of ORs that are co-
expressed in some rat OSNs [63]. The olfactory epithelium can be divided into four
expression zones. OSNs expressing the same OR are located inside the same zone,
where they are randomly distributed among OSNs expressing other ORs [61]. In
the olfactory bulb, the axons of neurons expressing the same OR converge to two
or at most a few glomeruli (Figure 1.7), which are arranged symmetrically between
the medial and lateral halves of the bulb [12,64,65].
This suggests that olfactory information is first roughly organized into four
large sets in the nose and then reorganized in the olfactory bulb into a sensory
map, which is identical in different individuals [4, 64]. In both the nose and bulb,
information derived from different ORs is strictly segregated: Each OSN in the nose
and each glomerulus in the olfactory bulb receives the input from one particular
OR. The glomerular convergence of OSNs expressing the same OR type probably
leads to an increase in the signal-to-noise ratio [4].
The studies of Malnic and co-workers provided evidence that the mammalian
olfactory system uses a combinatorial receptor coding scheme to encode odor iden-
tity and to discriminate odors [2,66]. As shown in Figure 1.8, an odorant receptor
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Figure 1.7: Patterns of connectivity between olfactory epithelium and
olfactory bulb. The olfactory epithelium can be subdivided in four zones of equal
surface area. A given OR gene is expressed in OSNs which are located within a
zone. Their axons converge onto one or a few glomeruli in each of the two halves
of the bulb. MOE, main olfactory epithelium; MOB, main olfactory bulb; AOB,
accessory olfactory bulb (taken from [4]).
can be activated by different odorant molecules, and, conversely, an odorant mole-
cule can activate more than one type of receptor, so that each odor leads to a
specific pattern of activation.
odorants receptors
Figure 1.8: Combinatorial receptor codes for odorants. The receptors
shown in color are those that bind the odorant on the left. Each OR can bind
several odorants, and each odorant can activate a set of ORs (modified from [66]).
1.6 Pairing Odors with Odorant Receptors
It took seven years from the discovery of the OR super-family to the first experi-
mental evidence that ORs indeed mediate odorant signals, mostly because odorant
receptors proved to be extremely difficult to express in heterologous cells. In fact,
ORs are retained in the endoplasmic reticulum due to inefficient folding and are
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poorly coupled to ER export machinery in non-native systems [67]. For this reason,
most ORs are still orphan receptors, i.e. their native ligands are yet not known.
Four strategies, described in the following, have been used to ”de-orphanize” odor-
ant receptors.
A first approach used genetic studies in Caenorhabditis elegans and indicated
that an odr-10 mutant lacked a seven-transmembrane receptor and was unable to
detect diacetyl [68]. This OR-odorant interaction was subsequently confirmed by
the heterologous expression of ODR-10 in HEK293 cells, where the activation of
the receptor by diacetyl was monitored using calcium imaging [69].
Another strategy, which made use of an adenovirus-mediated gene transfer
followed by electrophysiological detection of odorant-mediated responses, led to
the identification of octanal as an agonist for the rat I7 receptor [70] and enabled
the finding of an odorant with some antagonistic activity [70, 71]. This approach
was also used to identify lyral as an agonist for MOR23 [72].
A third approach for de-orphanizing ORs is to use gene targeting to co-
express the green fluorescent protein (GFP) in OSNs that endogenously express a
given OR gene. Cells are then isolated from the epithelium, loaded with a calcium-
sensitive fluorescent dye, and the green neurons which express both the OR and
GFP are identified and imaged for their responses to odorants. This method
enabled the discovery of acetophenone and benzaldehyde as agonists for the mouse
M71 receptor [73]. Furthermore, when the M71 coding region was replaced by rat
I7, responses to acetophenone and benzaldehyde were no longer seen and the cells
became, as expected, responsive to octanal [73].
Finally, also based on the rat I7-octanal pair, a heterologous expression sys-
tem was developed in human embryonic kidney (HEK293) cells [74]. To improve
the translocation of the OR to the plasma membrane of these cells, the N-terminal
part of rhodopsin (first 20 amino acids) was fused to the OR. G-protein subunits
that couple promiscuously to GPCRs were over-expressed in order to artificially
couple the OR to the IP3/Ca
2+ signalling pathway, allowing calcium imaging mea-
surements.
An analogous HEK293 expression system, but with different OR protein
modifications (the 5HT3 membrane import signal sequence followed by a c-myc
epitope was fused to the OR N-terminus) enabled the de-orphanization of the first
human OR: Helional was paired with OR17-40 [75]. This interaction was confirmed
by electrophysiological measurements in engineered Xenopus laevis oocytes [75].
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1.7 Aim and Scope of this Thesis
In order to establish a functional expression system for odorant receptors and de-
velop cell-based assays to study their specificity and sensitivity for odorant mole-
cules, this thesis focuses on the functional analysis of the human odorant receptor
OR17-40.
For the direct visualization of the receptor in living cells, different OR17-40
fusion proteins enabling expression and subcellular localization studies were con-
structed and functionally characterized (Chapter 3). To investigate the cellular
mechanisms responsible for its poor surface membrane targeting, the biogenesis and
membrane trafficking of OR17-40 was followed using a novel fluorescence labelling
strategy, which allowed the optical discrimination between membrane-inserted re-
ceptors and all translated receptors (Chapter 4). The selective labelling of cell
surface receptors also provided a tool for studying the effect of agonist or antago-
nist binding on the lateral diffusion of OR17-40 in HEK293 cell plasma membranes
(Chapter 5).
For efficient screenings of large odorant collections in microtiter plates, a
calcium imaging-based functional assay was developed (Chapter 6). Using chemical
derivatives of the cognate ligand helional, this assay enabled the investigation of the
structural properties of odorant molecules essential for OR17-40 binding and/or
activation.
Finally, a novel strategy for the miniaturization of functional odorant screen-
ing assays based on cell-derived native vesicles containing different OR subtypes
is described (Chapter 7).
Chapter 2
Experimental Techniques and
Procedures
This chapter deals with the materials and general methods used throughout this
work, unless otherwise stated. It includes the standard techniques for cell cultures,
transient and stable protein expression, calcium ion signalling, ACP labelling, flu-
orescence confocal microscopy, and FACS analysis.
2.1 Materials
Dulbecco’s modified Eagle’s medium (DMEM), fetal calf serum (FCS), Dulbecco’s
phosphate-buffered saline (D-PBS) and Lipofectamine2000 were from Invitrogen
(Breda, NL). Hygromycin B was from Calbiochem (Darmstadt, D). Puromycin
and penicillin/streptomycin were from Sigma (Buchs, CH).
The monoclonal anti-c-myc, Cy3 conjugate clone 9E10 was purchased from
Sigma (Buchs, CH). Paraformaldehyde was from Fluka (Buchs, CH).
The fluorescent indicator dyes Fluo-3 and FuraRed were from Molecular
Probes (Eugene, OR, USA) and the Calcium 3 assay kit from Molecular Devices
(Munich, D).
2.2 Cell Cultures and Transfection
2.2.1 HEK293 Cells
Human embryonic kidney cells (HEK293 cells) were cultured in Dulbecco’s mod-
ified Eagle medium (DMEM) supplemented with 2.2% or 10% fetal calf serum
(FCS). The cultures were grown at 37 oC in a humidified 5% CO2 atmosphere and
were split at regular time intervals.
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Sixteen to twenty hours before transfection, exponentially growing cells cul-
tured in DMEM containing 2.2% FCS were seeded either on sterile 25mm glass
cover slides (Hecht Assistent, Sondheim-Rhoen, D) or on 8-well chambered cov-
erglass slides (Lab-Tek, Naperville, IL, USA). Cells were transfected using the
calcium phosphate precipitation method [76], unless otherwise specified.
2.2.2 Odora Cells
Non-differentiated odora cells were grown in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% fetal calf serum and 100U/ml penicillin - 100µg/
ml streptomycin (PenStrep) in a humidified 95% air, 5% CO2 incubator at 34
oC.
For differentiation, cells were cultured in DMEM/PenStrep medium containing
10% FCS and 1µg/ml insulin, 20 µM dopamine and 100µM ascorbic acid (dopamine
stabilizer) in a humidified 95% air, 7% CO2 incubator at 39
oC for 5 to 7 days.
Differentiated odora cells were transfected using Lipofectamine2000 according
to the manufacturer’s instructions, with 2.5µg DNA and 10µl Lipofectamine2000
per milliliter of cells.
2.3 Stable Cell Line Selection
Exponentially growing HEK293 cells were seeded in a 12-well plate and each well
was transfected with 2.5µg receptor DNA and 2.5µg Gαq DNA using the calcium
phosphate precipitation method. 48 h after transfection, the medium was replaced
by the selection medium (DMEM containing 10% FCS, puromycin (20µg/ml) and
hygromycin B (200µg/ml)). Confluently growing cells were split in 6-well plates
and then expanded in 75 cm2 culture flasks containing the selection medium.
2.4 Immunocytochemistry
Cells expressing the c-Myc - OR17-40 construct together with a nuclear-targeted
GFP, or the c-Myc - OR17-40 - GFP construct, were fixed for 5 min in PBS
containing 4% paraformaldehyde. Cells were washed with PBS, blocked for 20min
with PBS containing 1% fetal calf serum and incubated for 1 h with the monoclonal
anti-c-myc, Cy3 conjugate clone 9E10, at a 1:50 dilution. Cells were then washed
three times with PBS and visualized by laser-scanning confocal microscopy. The
excitation was at 543 nm, and the emission was recorded using a 560 nm long pass
filter.
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2.5 ACP Labelling
Cells stably or transiently expressing ACP - OR17-40 or ACP - OR17-40 - GFP and
grown either on sterile 25mm glass cover slides or on 8-well chambered coverglass
slides, were labelled with Cy5 (5µM CoA-Cy5, 1µM AcpS and 10mM MgCl2
in D-PBS) for 30min. The labelling was performed at room temperature, unless
otherwise specified. Cells were then washed three times with D-PBS and visualized
by laser-scanning confocal microscopy. The excitation was at 633 nm, and the
emission was recorded using a 650 nm long pass filter.
2.6 Fluorescence Confocal Microscopy
Laser-scanning confocal micrographs were recorded using a 453/488 nm Ar-Kr laser
line or a 543 or 633 nm He-Ne laser line on a Zeiss LSM 510 microscope (Zeiss,
Jena, D) with a 63 x water (1.2 numerical aperture) objective. Detection and
distinction of fluorescence signals was achieved by appropriate filter sets using a
multi-tracking mode. Table 2.1 lists the filter sets when using one fluorophore in
single-tracking mode and Table 2.2 lists the filter sets when using two fluorophores
in multi-tracking mode. If possible, an additional dichroic mirror was used for the
multi-tracking mode to split the fluorescence emission into two channels.
Excitation Dichroic Emission
Line Mirror Filter
ECFP 458 nm HFT 458 LP 475
EGFP, EYFP, Alexa488 488 nm HFT 488 LP 505
Cy3, rhodamine 543 nm HFT 543 LP 560
Cy5, CypHer 633 nm HFT 633 LP 650
Table 2.1: Filter sets for one fluorophore and single-tracking mode.
2.7 FACS Analysis
Cells expressing OR17-40 - GFP, ACP - OR17-40 or ACP - OR17-40 - GFP labelled
with CoA-Cy5 were very briefly trypsinized, centrifuged for 4min at 1,200 rpm in
DMEM containing 10% FCS, resuspended in PBS and collected by centrifugation.
The pellet was finally resuspended in PBS at a density of about 1x106 cells/ml.
Fluorescence measurements were performed on a CyAn ADP LX 9 Color analyser
(DakoCytomation, FortCollins, CO, USA), using the 488 nm and 633 nm excitation
lines. The GFP fluorescence was detected in the FL1 (FITC) channel and the
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Excitation Dichroic Beam Emission
Line Mirror (HFT) Splitter (NFT) Filter
Cy3 and 543 nm BP 560-615
Cy5 633 nm UV/488/543/633 635 vis LP 650
ECFP and 458 nm 458 - BP 465-495
EYFP 488 nm 488 - BP 510-560
EGFP and 488 nm BP 505-550
Cy3 543 nm 488/543 545 LP 560
EGFP 488 nm BP 505-550
and Cy5 633 nm UV/488/543/633 635 vis LP 650
Table 2.2: Filter sets for two fluorophores and multi-tracking mode.
Cy5 signal in the FL8 (APC) channel. Analysis (Summit, DakoCytomation) was
performed on viable cells only, as determined by a gate on forward and side scatter.
2.8 Single-Cell Calcium Imaging
Twenty-four to forty-eight hours after transfection, cells grown on 25mm glass
cover slides were loaded by incubation at 37 oC for 30min in serum-free DMEM
containing the calcium ion indicator dyes Fluo-3-AM (3µM) and FuraRed-AM
(5µM). The dye loading medium was then exchanged against DMEM containing
10% FCS and incubation at 37 oC was continued for another 30min in order to
allow for cleavage of the ester. Calcium signalling measurements were performed
on a laser-scanning confocal microscope. Both dyes were excited at 488 nm and
the increase in Fluo-3 fluorescence intensity and decrease in FuraRed fluorescence
intensity were recorded and separated with appropriate filters (Fluo-3: BP 505-
550 nm; FuraRed: LP 560 nm).
For each experiment, odorant compounds were freshly diluted in D-PBS from
a stock solution of 1M in DMSO and 100µl was manually applied with a mi-
cropipette into the chamber. After each ligand application, ATP (100µM final
concentration) was added to the cells, as a control for the ability of the cells to
increase the Ca2+ ion concentration in general. ATP activates the P2y-type of
ATP receptor, which is present in HEK293 cells and which couples to the IP3
pathway [77].
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2.9 Ca2+ - FLEX Assay
Twenty-four hours prior to the calcium imaging assay, cells stably expressing the
receptor and Gαq were seeded in black wall/clear bottom 96-well plates (Greiner)
at a 80% confluence. On the day of measurement, cells were loaded for 1 h at 37 oC
with a calcium-sensitive dye (Calcium 3 assay kit, Molecular Devices) following the
manufacturer’s instructions. The change in fluorescence intensity of the calcium
dye upon agonist addition was recorded on the fluorescence plate reader FLEXsta-
tion (Molecular Devices). The FLEXstation’s integrated 8-channel pipettor deliv-
ered 50µl of 5x-concentrated odorant compounds within 2 seconds simultaneously
to 8 wells containing 200µl of cells. The intensity of fluorescence emission at
515 nm, following excitation at 485 nm, was monitored from the 8 wells simultane-
ously, during 250 s. After 180 s, 25µl of a 11x-concentrated (1,1mM) solution of
ATP was added to the wells.
Agonist response amplitudes were determined from the peak fluorescence,
baseline-corrected traces and normalized to the ATP response amplitude. The
amplitudes thus obtained were averaged over 9 to 20 wells expressing the same
construct and receiving the same stimulus. EC50 values and curves were derived
from the fit with the Hill-equation:
f(x) = m0 + ((m1 ∗ (xnH))/((CnH) + xnH))
with m0 = minimum, m1 = maximum, C = EC50 and nH = Hill coefficient.
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Chapter 3
Expression of the Human
Odorant Receptor OR17-40 in
Heterologous Cells
3.1 Introduction
As described in Chapter 1, the functional expression of ORs using OSNs, adeno-
virus-infected olfactory epithelia, and genetically engineered animals were success-
ful for a limited number of ORs. Nevertheless, these model systems have practical
limitations. For example, odorant-responsive OSNs are difficult to maintain in
primary culture [78], viral-mediated gene transfer does not consistently yield func-
tional OR expression [79], and creating genetically engineered animals for each
member of the OR super-family would be expensive and would not be suitable for
high-throughput applications.
For these reasons, efficient heterologous expression systems need to be de-
veloped. The choice of a suitable cell line is influenced by two conditions: On
one hand it should allow the functional expression of ORs, and on the other hand
provide the molecular components of the signal transduction machinery to couple
OR activation to a cellular response.
HEK293 cells have been used for the functional expression of several odorant
receptors [74, 75, 80]. These cells are easy to handle and allow the monitoring of
odorant responses by the activation of the DAG/IP3 signalling pathway followed by
an intracellular calcium ion release, which can be detected using calcium-sensitive
indicator dyes [75, 79]. Alternatively, some odorant receptors were expressed in a
cell line derived from the rat epithelium [81,82], odora (olfactory-derived odorant
receptor activatable), which can be induced to differentiate into cells that have the
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same properties as mature OSNs. Differentiated odora cells were shown to express
the olfactory G protein Golf, the adenylyl cyclase type III (ACIII), and the β
subunit of the olfactory cyclic nucleotide-gated channel (oCNGβ) [81], and can be
used for studying OR activation by monitoring the calcium influx through the CNG
channel with calcium-sensitive indicator dyes. ORs were shown to be expressed in
the plasma membrane of differentiated odora cells, while in undifferentiated odora
cells, ORs were not properly translocated, even though the receptors were released
to the Golgi apparatus and endosomes [82]. The efficient translocation of ORs to
the plasma membrane is thus an essential aspect in developing functional assays
for the study of OR activation.
For some GPCRs, accessory proteins are required for correct receptor target-
ing to the cell surface [83]. For instance, NinaA was found to mediate cell surface
expression of Rhodopsin 1 in Drosophila melanogaster, while RanBP2 promotes the
translocation of mammalian cone opsin [84]. A novel family of chaperone proteins,
called RAMPs for receptor activity modifying proteins, has been found to inter-
act with the calcitonin receptor-l ike receptor (CRLR), assisting in the transport
of CRLR to the cell surface, and defining the glycosylation state and recognition
properties of the receptor [85]. The M10 and M1 family of MHC class I proteins
and β2 microglobulin are helper proteins for the putative mammalian pheromone
receptors V2Rs [86], and OR83b, an atypical odorant receptor found in Drosophila,
was recently shown to interact with Drosophila odorant receptors [87].
Similarly, several accessory proteins were found to enhance the plasma mem-
brane translocation of some mammalian odorant receptors in native and heterol-
ogous cells. ODR-4, a membrane protein that is expressed exclusively on intra-
cellular membranes of chemosensory neurons, was shown to be required for the
translocation of a subset of odorant receptors (e.g. ODR-10) to the cilia of olfac-
tory neurons in C. elegans [88]. Its co-expression enhanced the surface expression
of an epitope-tagged rat odorant receptor in undifferentiated odora cells, as well as
in CHO cells [82]. This indicates that ODR-4 is able to improve plasma membrane
trafficking of a mammalian OR, although its co-expression did not have any effect
on the surface expression of another rat odorant receptor, OR5 [82].
Very recently, three other accessory proteins were found by screening modi-
fied LongSAGE (serial analysis of gene expression) libraries from single olfactory
neurons and from neurons of the vomeronasal organ of mouse [89]. Candidate genes
with open reading frames (ORFs) that encode membrane-associated proteins or
with similarities to known chaperones were cloned from olfactory epithelium cD-
NAs. Each cDNA was co-transfected with a mouse OR (mOR203-1) tagged with
an epitope into HEK23 cells, and OR cell surface expression was measured by im-
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munocytochemistry. Two unrelated clones enhanced both the number and stain-
ing intensity of mOR203-1 cell surface expression: RTP1, (receptor transporting
protein 1 ) and REEP1 (receptor expression enhancing protein 1 ). RTP2, a close
relative of RTP1 was also found to enhance cell surface expression. The effect of
the co-expression of these proteins was investigated on three other mouse odorant
receptors and on the rat I7 receptor. The surface expression of the rat I7 was sig-
nificantly lower than for the other ORs tested, but still enhanced by the accessory
proteins [89].
In addition to accessory proteins, the formation of homo- or heterodimers
might play a role in OR trafficking [90, 91]. For example, by hiding specific ER
retention signals, oligomerization might favor the entry of the completed proteins
in the export system, thus allowing its correct trafficking. A role for dimerization
in GPCR export from the ER was first suggested by a series of studies on the
metabotropic GABAb receptors [92]. When expressed alone, the GABAb R1 re-
ceptor is retained in the ER as an immature protein, while GABAb R2, although
properly targeted to the plasma membrane, cannot bind GABA. When the two
receptors are co-expressed, both reach the plasma membrane as a complex that
can bind GABA [92]. Other examples of heterodimers are the T1R taste recep-
tors: T1R3 is not functional when expressed alone in heterologous cells, but forms
heterodimers with T1R2, thereby mediating sweet taste, or combines with T1R1
to form a receptor that is broadly responsive to L-amino acids and monosodium
L-glutamate, which has an umami taste [4]. The heterodimerization of the NK1
receptor and the µ-opioid receptor was also shown to regulate receptor trafficking
and resensitization [93].
The β2-adrenergic receptor (β2-AR) is expressed in OSNs, where it seems to
be involved in axon guidance [11]. Recently, co-expression of β2-AR, but not of
other AR subtypes that are also expressed in neurons, was shown to increase the
cell surface expression of a mouse odorant receptor (M71) in HEK293 cells [94].
Co-immunoprecipitation of the β2-AR with the M71 receptor indicated that the
two receptors physically interact.
In this chapter, the expression and subcellular localization of the human
OR17-40 receptor in HEK293 cells and in differentiated odora cells with and with-
out the co-expression of the accessory proteins ODR-4, β2-AR, and RTPs are
reported.
To enable such studies, the receptor needs to be visualized in living cells. The
classical way of labelling would be by means of antibodies. In recent years however,
new techniques have been developed, e.g. incorporation of non-natural fluorescent
amino acids [95] or fusion to autofluorescent proteins [96]. In addition, post-
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translational in vivo labelling methods have been introduced, where the fluorescent
label is covalently or non-covalently attached to a fusion tag or fusion protein
[97–102].
In the present study, we have chosen three different approaches for labelling
OR17-40 in cells: (i) A C-terminal fusion to the green fluorescent protein (GFP)
was used for the real-time visualization of the receptor in living cells, (ii) an N-
terminal fusion of an epitope tag allowed the detection of the receptor by a fluo-
rescent antibody on fixed cells, and (iii) the acyl carrier protein (ACP) fused to
the receptor N-terminus enabled enzymatic post-translational labelling with fluo-
rescent substrates in living cells. The technical aspects of these approaches and
their use for comparing expression and plasma membrane trafficking of OR17-40
in different cell lines are discussed in detail in this chapter.
3.2 Experimental Procedures
3.2.1 Materials
OR17-40 cDNA was a kind gift from H. Hatt (Ruhr-Universita¨t, Bochum, D).
ODR-4 was kindly provided by C. Bargmann (University of California, San Fran-
cisco, USA). The odora cell line was a kind gift from D. Hunter (Tufts University,
Boston, USA).
The synthetic oligonucleotides were purchased from MWG (Ebersberg, D).
pBluescript II KS+ and the QuickChange site-directed mutagenesis kit were from
Stratagene (La Jolla, CA, USA). pEAK8 was from Edge BioSystems (Gaithers-
burg, MD, USA). pEGFP-N1 and pEGFPnuc were from Clontech (Palo Alto, CA,
USA). Restriction enzymes were purchased from New England Biolabs (Ipswich,
MA, USA). DNA sequencing was done by Microsynth (Balgach, CH).
Octadecyl rhodamine B (R18) dye was from Molecular Probes (Eugene, OR,
USA). pACP-NK1, CoA-Cy5 and AcpS were a kind gift from N. George and K.
Johnsson (LIP-ISIC, EPFL, CH).
Cell culturing, cell transfection and preparation, immunocytochemistry, ACP
labelling, fluorescence confocal microscopy, and single-cell calcium imaging, were
performed as described in Chapter 2.
3.2.2 cDNA Constructs of OR17-40
wild-type OR17-40 — For a better plasma membrane localization of the odor-
ant receptor, the 20 first amino acids of the bovine rhodopsin [74] followed by
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a NdeI site were added at the receptor N-terminus by PCR using the follow-
ing primers: OR17-40-fo: 5’- TCT GAT ATC GC ACC ATG AAC GGG ACC GAG GGC
CCA AAC TTC TAC GTG CCT TTC TCC AAC AAG ACG GGC GTG GTG CAT ATG CAG
CCA GAA TCT GGG GCC AAT GGA ACA GTC ATT GCT GAG -3’; OR17-40-rev: 5’-
CGC GAT CGA TGC GGC CGC TCA AGC CAG TGA CCG CCT CCC TGT GAG -3’; and
the resulting 1.1 kb EcoRV - NotI fragment was subcloned both into the cloning
vector pBluescript II KS+ and into the mammalian expression vector pEAK8,
yielding pBS::OR17-40 and pEAK8::OR17-40, respectively.
OR17-40 - GFP — pEAK8::OR17-40 - GFP was obtained by replacing the stop
codon of OR17-40 by a BamHI site using site-directed mutagenesis on pBS::OR17-
40. GFP was amplified by PCR from pEGFP-N1 using the following primers:
GFP-fo: 5’- CGC GGA TCC ATG GTG AGC AAG GGC GAG GAG CTG -3’; GFP-rev:
5’- CGC GAT CGA TGC GGC CGC TTA CTT GTA CAG CTC GTC CAT GCC -3’; and
the resulting 750 bp BamHI - NotI fragment was subcloned into pBS::OR17-40.
OR17-40 - GFP was cut out with EcoRV and NotI and subcloned into pEAK8.
c-Myc - OR17-40 — pEAK8::c-Myc - OR17-40 was obtained by adding the
sequence EQKLISEEDL (residues 410-419) of the human oncogene product c-myc
between the rhodopsin membrane import sequence and the coding sequence of the
receptor using site-directed mutagenesis and the following primers: myc-fo: 5’-
GTG CCT TTC TCC AAC AAG ACG GGC GTG GTG CAT AT G GCA TCA ATG CAG AAG
CTG ATC TCA GAG GAG GAC CTG GGA TCC CAG CCA GAA TCT GGG GCC AAT GGA
ACA GTC -3’; myc-rev: 5’- GAC TGT TCC ATT GGC CCC AGA TTC TGG CTG GGA
TCC CAG GTC CTC CTC TGA GAT CAG CTT CTG CAT TGA TGC CAT ATG CAC CAC
GCC CGT CTT GTT GGA GAA AGG CAC -3’.
ACP - OR17-40 — For cloning of pEAK8::ACP - OR17-40, a BamHI site was
added between the rhodopsin membrane import sequence and the coding sequence
of the receptor in pBS::OR17-40 using site-directed mutagenesis . The ACP frag-
ment was amplified by PCR from pACP-NK1 using the following primers: ACP-fo:
5’- GGC ATC TC CAT ATG ATG AGC ACT ATC GAA GAA CGC GTT AAG -3’; ACP -
rev: 5’- GTA GGA TCC CGC CTG GTG GCC GTT GAT GTA ATC AAT GGC -3’. The
resulting 240 bp fragment was subcloned into pBS::OR17-40 digested with NdeI
and BamHI. ACP - OR17-40 was cut out with EcoRV and NotI and subcloned
into pEAK8.
c-Myc - OR17-40 - GFP and ACP - OR17-40 - GFP — The double-tagged
receptors c-Myc - OR17-40 -GFP and ACP - OR17-40 - GFP were obtained by di-
26 3 - Heterologous Expression of OR17-40
gesting pEAK8::c-Myc - OR17-40 or pEAK8::ACP - OR17-40 and pEAK8::OR17-
40 - GFP with KpnI and NotI and ligating the OR17-40 - GFP fragment into
pEAK8::c-Myc- OR17-40 or pEAK8::ACP - OR17-40 respectively.
glyco - OR17-40 — To increase the glycosylation state of OR17-40, the amino
acids 14 to 24 of the neurokinin 1 receptor (NISTNTSEPN) were added after the
rhodopsin membrane import sequence in pBS::ACP - OR17-40 or in pBS::OR17-40
- GFP. This was done using site-directed mutagenesis and the following primers:
glyco-fo: 5’- GGC CCA AAC TTC TAC GTG CCT TTC TCC AAC AAG ACG GGC GTG
GTG ATT AAT ATC TCC ACT AAC ACC TCG GAA CCC AAT CAT ATG CAG CCA GAA
TCT GGG GCC AAT GGA ACA GTC ATT GCT GAG -3’; glyco - rev: 5’- CTC AGC AA
T GAC TGT TCC ATT GGC CCC AGA TTC TGG CTG CAT ATG ATT GGG TTC CGA GG
T GTT AGT GGA GAT ATT AAT CAC CAC GCC CGT CTT GTT GGA GAA AGG CAC GT
A GAA GTT TGG GCC -3’. glyco-ACP - OR17-40 and glyco OR17-40 - GFP were
cut out with EcoRV and NotI and subcloned into pEAK8.
All plasmids were verified by restriction analysis and DNA sequencing.
The different OR17-40 constructs are illustrated in Figure 3.1.
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Figure 3.1: Membrane topology of the OR17-40 cDNA constructs show-
ing the different C-terminal and N-terminal modifications. (A) Wild-type
OR17-40; (B) OR17-40 - GFP; (C) c-Myc - OR17-40; (D) c-Myc - OR17-40 -
GFP; (E) ACP - OR17-40; (F) ACP - OR17-40 - GFP. Rho, bovine rhodopsin
membrane import sequence; ACP, acyl carrier protein; EGFP, enhanced green flu-
orescent protein.
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3.2.3 ACP Labelling
The post-translational labelling method used for this work is based on the enzy-
matic modification of ACP by phosphopantetheine transferase (PPTase), leading to
the transfer of 4’-phosphopantetheine from co-enzyme A (CoA) to a serine residue
of ACP, which is genetically fused to the protein of interest (Figure 3.2). Fluores-
cent dyes attached to the phosphopantetheine on CoA are transferred to ACP to-
gether with 4’-phosphopantetheine during the labelling process. The ACP/PPTase
pair used here is derived from Escherichia coli. PPTase from E. coli (AcpS) can
be easily purified and possesses a relative narrow substrate specificity with respect
to ACP [103].
protein of interest
protein of interest
Cell
CellPPTase
- 3',5'-ADP
ACP
ACP
Figure 3.2: ACP labelling technique. The fluorescent label (star) attached
to CoA is transferred together with 4’-phosphopantetheine by PPTase to the ACP
protein, which is genetically fused to the extracellular side of the protein of interest
(taken from [99]).
3.3 Results and Discussion
3.3.1 Subcellular Localization of OR17-40 in HEK293 Cells
Functionality of the Tagged OR17-40 Receptors — Studies on tagged odor-
ant receptors have reported that N- or C-terminal modifications could impair re-
ceptor activity. For example, the addition of a small epitope tag on the C-terminus
of the mouse mOR-EG receptor completely abolished its odorant responsiveness,
probably by disrupting its coupling to G proteins [104]. In contrast, the C-terminal
fusion of the rat I7 receptor to EGFP was shown not to affect ligand binding or
downstream signalling [105], suggesting that different ORs do not tolerate in the
same manner such modifications. Therefore, we first verified that the N- or C-
terminal modification of OR17-40 by different tags did not abolish the receptor
responsiveness to its cognate ligand helional.
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Figure 3.3: Single-cell calcium imaging of HEK293 cells expressing the
wild-type OR17-40 receptor together with Gαq. Cells were loaded with
the calcium ion indicator dyes Fluo-3 and FuraRed and stimulated with 100 µM
helional at the time indicated by the arrow. Changes in fluorescence intensities
were recorded using laser-scanning confocal microscopy.
The co-expression of the G protein Gαq together with each of the receptor
fusion constructs allowed the study of OR activation by calcium imaging. The
addition of helional induced a transient intracellular calcium ion increase, which
could be detected by the calcium-sensitive fluorescent dyes Fluo-3 and FuraRed,
in HEK293 cells transiently expressing OR17-40 - GFP, c-Myc - OR17-40, ACP -
OR17-40 or ACP - OR17-40 - GFP together with Gαq. The kinetics of the calcium
responses of the different constructs was similar to that of the wild-type receptor
(Figure 3.3), whereas none of the constructs responded to the non-activating con-
trol substance piperonal [75]. We thus conclude that modifications at both the C-
or N-terminus of the receptor do not affect OR-mediated signalling.
EGFP fusion — First subcellular localization studies of OR17-40 in HEK293
cells were performed using the C-terminal fusion of the receptor to EGFP, which
has been shown to be well suited for studying GPCR localization and trafficking
in living cells [106,107].
As shown in Figure 3.4, OR17-40 - GFP is mainly expressed in intracellular
membranes and, although part of the GFP fluorescence signal co-localizes with
the fluorescence of the lipid dye octadecyl rhodamine B (R18), it is impossible
to distinguish the membrane-inserted receptors from those which are trapped in
intracellular compartments.
Immunocytochemistry — To only label the receptors which are correctly translo-
cated to the plasma membrane, we fused a c-myc epitope to the N-terminus of
OR17-40. This small (10 amino acids) modification with respect to the wild-type
receptor is not likely to disturb its membrane trafficking. Moreover, the use of a
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Figure 3.4: Subcellular localization of OR17-40 - GFP construct in
HEK293 cells. Fluorescence confocal micrographs showing OR17-40 - GFP fu-
sion construct transiently expressed in HEK293 cells. The cell membrane is stained
with R18 dye. (A) OR17-40 - GFP. (B) Membrane dye R18. (C) Transmission
image of the same area with fluorescence micrographs A and B superimposed. Scale
bar indicates 10 µm.
fluorescent antibody raised against this extracellular epitope allows the selective
visualization of the membrane-inserted receptors, thus avoiding background signal
from intracellularly trapped receptors (Figure 3.5).
This labelling method proved to be very specific, since all antibody-labelled
cells co-expressed the transfection marker GFPnuc (GFP with a nuclear import
sequence). The number of cells exhibiting a detectable antibody labelling was
low (about 5 to 10% of the transfected cells). Many labelled cells had a rather
faint membrane staining, reflecting a low level of membrane-inserted receptors, as
compared to cells expressing a well-localized GPCR, the β2-adrenergic receptor,
also tagged with a c-myc epitope (data not shown).
It should be pointed out that, in order to avoid receptor internalization due to
antibody cross-linking [108,109], the cells need to be fixed prior to the incubation
with the antibody. This method is therefore not suited for following receptor
dynamics in living cells.
ACP labelling — The ACP labelling technique, which allows the selective flu-
orescence labelling of membrane proteins in living cells, enables real time-course
studies to be performed. Figure 3.6 (A-C ) shows Cy5-labelled ACP - OR17-40 in
the plasma membrane of HEK293 cells.
Moreover, a double-tagged OR17-40 fusion construct, with ACP genetically
fused to the receptor N-terminus and GFP to the C-terminus, allows the optical
distinction of the cell surface receptors, by means of the Cy5 label, from the whole
population of translated receptors participating to the GFP fluorescence. This
also allows the comparison of the amount of well-translocated ORs in cells with
different expression levels.
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Figure 3.5: Subcellular localization of c-Myc - OR17-40 construct in
HEK293 cells. Fluorescence confocal micrographs showing non-permeabilized
HEK293 cells transiently expressing c-Myc -OR17-40 construct together with a
nuclear-targeted GFP and labelled with a Cy3-conjugated anti-c-myc antibody. (A)
Anti-c-myc antibody. (B) GFP-stained nucleus. (C) Transmission image of the
same area with fluorescence micrographs A and B superimposed. Scale bar indi-
cates 10 µm.
Figure 3.6 (D-F ) shows the typical subcellular distribution of the double-
tagged receptor construct in HEK293 cells. In general, although a limited amount
of the translated ORs translocate to the plasma membrane, most of them are
trapped in intracellular membranes. Interestingly, cells having a low expression
level (low GFP fluorescence) exhibit a higher amount of membrane-inserted re-
ceptors, as revealed by a higher Cy5 fluorescence on the cell surface (Figure 3.6
(G-I )). It is likely that ORs are less efficiently folded due to a lack of chaperones
and that they tend to aggregate in the ER of highly expressing cells. This will be
discussed in more detail in Chapter 4, which deals with the trafficking of OR17-40.
On the other hand, cells expressing ACP - OR17-40 - GFP and grown at 34 oC or
31 oC, in order to slow down OR biosynthesis and enhance folding efficiency, did
not exhibit a better cell surface localization of the receptor (data not shown).
Furthermore, since the Cy5 fluorescence intensity in the membrane of cells
expressing either ACP - OR17-40 - GFP or ACP - OR17-40 was similar, we can
conclude that the fusion to GFP does not impair the membrane trafficking of the
receptor.
Increasing the glycosylation state of the receptor — Recently, Katada et
al. showed that the glycosylation of ORs was critical for their translocation to the
plasma membrane of heterologous cells [104]. Indeed, removal of the N-terminal
glycosylation site of mOR-EG, a mouse odorant receptor, completely impaired its
membrane trafficking to the cell surface of HEK293 cells. On the other hand, cell
surface expression of this receptor was greatly enhanced by the addition of extra N-
terminal glycosylation sequences, for instance by the fusion of a bovine rhodopsin
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Figure 3.6: Subcellular localization of ACP - OR17-40 and ACP - OR17-
40 -GFP fusion constructs in HEK293 cells. Confocal micrographs showing
HEK293 cells transiently expressing ACP - OR17-40 (A, B, C) or ACP - OR17-
40 - GFP (D, E, F and G, H, I) and labelled with CoA-Cy5. (A, D, G) Cy5
channel. (B) Transmission channel. (E, H) GFP channel. (C, F, I) Transmission
images of the same areas with fluorescence micrographs of the two other columns
superimposed. Scale bar indicates 10 µm.
membrane-import sequence, containing two additional glycosylation sites [104].
The neurokinin 1 receptor (NK1R), a GPCR which is very well translocated
to the plasma membrane of HEK293 cells, has two glycosylation sites in its ex-
tracellular N-terminal part, that are located at positions 14 and 18 in the NK1R
amino acid sequence. We therefore added the amino acid sequence NK1R(14-24)
to the N-terminus of the ACP-OR17-40 or the OR17-40 - GFP fusion constructs,
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just after the bovine rhodopsin membrane-import sequence.
The expression and subcellular localization of these receptor constructs tran-
siently expressed in HEK293 were first investigated by confocal microscopy (Figure
3.7, A and B), which revealed that most of the receptors were still located intra-
cellularly. For a more quantitative comparison of the plasma membrane expression
of the modified and unmodified receptor constructs, we performed FACS analysis
(Figure 3.7, C and D): Cells expressing glyco-ACP - OR17-40 and labelled with
CoA-Cy5 did not exhibit a higher amount of cell surface receptors as compared
with the unmodified receptor construct.
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Figure 3.7: Subcellular localization of glyco-ACP - OR17-40 and glyco-
OR17-40 - GFP fusion constructs in HEK293 cells. (A and B) Confocal
micrographs showing HEK293 cells transiently expressing Cy5-labelled glyco-ACP
- OR17-40 (A) or ACP - OR17-40 - GFP (B). Scale bar indicates 10 µm. (C and
D) FACS analysis performed on HEK293 cells transiently expressing glyco-ACP -
OR17-40 and labelled with CoA-Cy5 (D) showed no higher cell surface receptor
level as compared to the unmodified ACP - OR17-40 receptor construct (C).
3.3.2 Subcellular Localization of OR17-40 in Odora Cells
The transient expression of OR17-40 in other heterologous cells, such as Chinese
hamster ovary (CHO) cells, polarized MCCK cells, and neuronal N1E cells, yielded
the same results as described for HEK293 cells (data not shown): Receptors were
mainly retained in intracellular compartments.
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The odora cell line, which is derived from the rat olfactory epithelium, was
expected to provide a higher cell surface expression of the odorant receptors. As
OR plasma membrane targeting was shown to require the differentiation of odora
cells [82], OR17-40 was transiently expressed in odora cells that had been cultured
for 5 to 7 days under differentiation conditions. Differentiated cells exhibited a
bipolar morphology, with long processes extending over several tens of micrometers
(Figure 3.8B), whereas undifferentiated cells had an epithelial morphology (Figure
3.8A).
Figure 3.8: Morphology of odora cells. Micrographs showing undifferentiated
(A) and differentiated (B) odora cells. Scale bar indicates 20 µm.
The subcellular localization of the OR17-40 - GFP fusion construct in differ-
entiated odora cells is shown in Figure 3.9A. The cell surface expression of OR17-40
- GFP is not significantly improved in this cell line. A small fraction of receptors
reaches the plasma membrane of differentiated odora cells, as detected by the
fluorescence of Cy5-labelled ACP - OR17-40 (Figure 3.9B). In general, OR17-40
subcellular localization in odora cells is similar to the one seen in HEK293 cells,
with the majority of the receptors located intracellularly.
Figure 3.9: Subcellular localization of OR17-40 - GFP and ACP - OR17-
40 fusion constructs in differentiated odora cells. Confocal micrographs
showing differentiated odora cells transiently expressing OR17-40 - GFP (A) or
Cy5-labelled ACP - OR17-40 (B) fusion constructs. Scale bar indicates 20 µm.
34 3 - Heterologous Expression of OR17-40
For this reason, and because HEK293 cells present several advantages over
odora cells (easier cell culturing, no need of differentiation, better transfection
efficiencies and lower autofluorescence), most of the experiments of this thesis will
be performed on HEK293 cells.
3.3.3 Co-expression of OR17-40 with Helper Proteins
To investigate if ODR-4, β2-AR or the RTP proteins would improve OR17-40
membrane trafficking in HEK293 cells, we co-expressed these proteins together
with the ACP - OR17-40 - GFP double-tagged construct. In order to obtain data
on a statistically relevant number of cells, we performed a fluorescence-activated
cell sorting (FACS) analysis on Cy5-labelled cells. This approach enabled us to
determine, on one hand, the total fluorescence intensity from all translated recep-
tors via the GFP fluorescence emission in individual cells, and, on the other hand,
the fluorescence intensity from the membrane-inserted receptors, through the Cy5
fluorescence emission.
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Figure 3.10: FACS analysis of HEK293 cells expressing the ACP - OR17-
40 - GFP construct with or without the accessory proteins. Cell surface
expression (CoA-Cy5 intensity) versus total cellular expression (GFP intensity)
of individual cells. (A) Untransfected HEK293 cells. (B) Untransfected HEK293
cells labelled with CoA-Cy5. (C-F) HEK293 cells expressing ACP - OR17-40 -
GFP (C); with ODR-4 (D); with β2-AR (E); and with RTP1 and RTP2 (F).
Analysis was performed on 75,000 cells for each condition (50,000 for A).
As shown in Figure 3.10, none of the different helper proteins enhanced OR17-
40 cell surface expression: There is no significant increase in Cy5 fluorescence
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intensity as compared with cells expressing the ACP - OR17-40 - GFP construct
alone. It can however be noticed that cells with a low or even non-detectable GFP
signal and reflecting an overall low receptor expression level have a higher Cy5
intensity, corresponding to a higher cell surface staining. These results confirm the
observations on individual cells obtained by fluorescence confocal microscopy.
3.4 Conclusions
To study the expression and subcellular localization of the human odorant receptor
OR17-40 in heterologous cells, we constructed different OR17-40 fusion proteins
which enabled us to follow receptor biogenesis and trafficking: (i) The enhanced
green fluorescent protein (EGFP) allowed a continuous labelling of all translated
receptors, (ii) a c-myc tag enabled the selective labelling of cell surface receptors on
fixed cells, and (iii) the fusion to the acyl carrier protein (ACP) provided a tool to
selectively visualize plasma membrane receptors in living cells. We transiently ex-
pressed these constructs in HEK293 cells, a cell line which is well suited for GPCR
expression [74, 75, 80] and in odora cells, a cell line derived from the rat olfactory
epithelium [81]. Both cell lines exhibited low cell surface expression of ORs. Our
labelling experiments indicated that the majority of the translated receptors were
trapped in intracellular compartments, with a better plasma membrane localiza-
tion of OR17-40 in low expressing cells. Since HEK293 cells are easier to handle
than odora cells, and since OR membrane localization in odora cells was not im-
proved as compared to the one in HEK293 cells, we decided to use HEK293 cells
for further experiments.
Although a number of accessory proteins (ODR-4, the β2-adrenergic recep-
tor, or the RTP proteins) were shown to promote translocation of some ORs to
the plasma membrane of heterologous cells, we did not achieve a better cell sur-
face trafficking of OR17-40 by the co-expression of these proteins, as indicated by
FACS analysis. It is possible that different ORs require different helper proteins to
enhance cell surface expression and that the accessory protein specific to OR17-40
remains to be discovered. On the other hand, as the co-expression of the RTP
proteins, which are proteins derived from mouse, induced a significantly lower en-
hancement of cell surface expression of the rat I7 receptor than of three different
mouse ORs [89], it is likely that such accessory proteins are species-specific. Re-
cently, a full-length human cDNA that is homologous to the C. elegans odr -4 gene
at the protein level across nearly the entire gene was isolated [110]. The protein
has not been tested so far for complementation of OR trafficking activity in het-
erologous cells, but it is possible that this human ODR-4 could increase cell surface
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targeting of human odorant receptors, such as OR17-40.
Chapter 4
Biogenesis and Trafficking of the
Human Odorant Receptor
OR17-40 in HEK293 Cells
4.1 Introduction
In order to establish efficient cell-based assays in which large collections of odor-
ant molecules can be screened and which are generally applicable for all members
of the OR super-family, it is necessary to devise a system in which the receptors
are efficiently transported to the cell surface. A first step in this direction is the
investigation of cellular mechanisms responsible for inefficient OR surface expres-
sion. Monitoring the different stages of OR expression and trafficking, from its
biosynthesis to its insertion in the plasma membrane, can thus provide valuable
information for manipulating these processes in vivo.
The subcellular localization of ORs is classically assessed by immnocytochem-
istry, using fluorescent antibodies generated either against specific ORs [111–113]
or against an epitope tag fused to the OR extracellular part [75,80,104,114]. How-
ever, antibody labelling in living cells can lead to receptor cross-linking [108,109],
which might induce an artifactual behavior in receptor mobility. Other side effects
might be caused by the size of the antibodies, which are often larger than the re-
ceptor itself and can therefore prevent the investigation of several processes, such
as receptor endocytosis.
Alternatively, OR subcellular localization in living cells can be monitored
using a genetic fusion of the receptor to the green fluorescent protein (GFP) [105,
114]. This approach allows the continuous visualization of all receptors in real
time. However, since GFP labels all intracellular and membrane-inserted receptors
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in the same color, the selective analysis of cell surface receptors can be impeded
by a strong intracellular fluorescent background.
In this chapter, we took advantage of a double-tagged OR17-40 receptor
construct, where the extracellular N-terminal part was fused to the ACP protein
and the intracellular C-terminus was fused to GFP, to resolve for the first time
sequential stages in the life cycle of an odorant receptor. This combination of
tags did not interfere with the biological function of the odorant receptor and
enabled not only to visualize the receptor right after its biosynthesis in intracellular
compartments, but also to optically distinguish and quantitatively compare surface
(Cy5-labelled) and total (GFP-tagged) receptor pools at any time in living cells.
Moreover, as the small fluorophore added by ACP labelling [99] does not prevent
receptor endocytosis, this method allowed us to reveal unexpected constitutive
internalization in the absence of an agonist.
4.2 Experimental Procedures
4.2.1 Materials
The plasmids pECFP-ER and pECFP-Golgi were purchased from Clontech (Palo
Alto, CA, USA). Lipofectamine2000 was from Invitrogen (Breda, NL). Transferrin-
alexa488 was from Molecular Probes (Eugene, OR, USA). Sucrose was from Sigma
(Buchs, CH). CoA-CypHer was kindly synthesized by A. Peer (LCAN-ISIC, EPFL,
CH). Helional and α-methyl-cinnamaldeyde were kindly provided by Dr C. Margot
(Firmenich SA, Geneva, CH).
4.2.2 Fluorescence Confocal Microscopy of OR17-40 Bio-
genesis and Trafficking in HEK293 Cells
HEK293 cells grown on 25mm diameter glass coverslips in 6-well plates were trans-
fected with ACP - OR17-40 - GFP cDNA together with either pECFP-ER or
pECFP-Golgi at a 4:1 ratio using the Lipofectamine2000 reagent according to the
manufacturer’s protocol. At different time points after the onset of transfection,
samples were visualized by laser-scanning confocal microscopy. Detection and dis-
tinction of both the receptor (GFP fluorescence) and the ER or Golgi marker was
achieved by appropriate filter sets (see Chapter 2) using a multitracking mode.
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4.2.3 Receptor Internalization Studies by Fluorescence Mi-
croscopy
The clathrin internalization pathway of HEK293 cells was blocked by 10min in-
cubation at 37 oC in D-PBS containing 0.45M sucrose [115]. Cells transiently or
stably expressing the ACP - OR17-40 fusion protein were labelled with the pH-
sensitive dye CoA-CypHer (5µM CoA-CypHer, 1µM AcpS and 10mM MgCl2 in
D-PBS containing 0.45M sucrose) for 30min at 37 oC. Cells were then washed 3
times with D-PBS containing 0.45M sucrose. CypHer fluorescence was visualized
on a home-built fluorescence microscope as described in Chapter 5 (Excitation:
632.8 nm HeNe; Q645LP dichroic mirror; HQ710/120 filter).
For subcellular co-localization studies with fluorescently labelled transferrin,
50µg/ml Tf-alexa488 was added to the cells during the ACP labelling with 5µM
CoA-Cy5. Cells were visualized by fluorescence confocal microscopy. Detection
and distinction of Tf-alexa488 and the Cy5-labelled receptors was achieved by
appropriate filter sets (see Chapter 2) using a multitracking mode.
To quantify the effect of agonist or antagonist binding on the receptor inter-
nalization, cells transiently expressing the ACP - OR17-40 - GFP double-tagged
construct were incubated at 37 oC either overnight with 300µM α-methyl-cinnamal-
dehyde, or 15min and 1 h with 200µM helional, and labelled with CoA-Cy5 ac-
cording to the protocol described in Chapter 2 (for the sample with antagonist,
ACP labelling was performed in presence of 300µM α-methyl-cinnamaldehyde).
Cells were then analyzed by FACS.
Cell culturing and preparation, calcium imaging, confocal microscopy and
FACS analysis were performed as described in Chapter 2. Cloning steps for the
ACP - OR17-40 and ACP - OR17-40 - GFP fusion constructs are detailed in
Chapter 3.
4.3 Results and Discussion
4.3.1 Functionality of ACP - OR17-40 and ACP - OR17-40
- GFP
In order to investigate if the fusion of the different peptide tags would interfere
with the biological function of OR17-40, we performed calcium imaging on cells
stably expressing ACP - OR17-40 or ACP - OR17-40 - GFP together with Gαq.
As shown in Figure 4.1, both cell lines responded to the cognate ligand helional
in a dose-dependent manner, with an EC50 of 108.0 ± 4.2µM for ACP - OR17-
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40 and of 90.7 ± 7.9µM for ACP - OR17-40 - GFP, which are comparable to
the EC50 measured for the wild-type receptor (98.7 ± 4.7µM). Furthermore, even
Cy5-labelled ORs retained their full activity (Figure 4.1).
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Figure 4.1: Functional expression of ACP - OR17-40 and ACP - OR17-
40 - GFP. Concentration-response relations of the cognate ligand helional on cal-
cium ion release in HEK293 cells stably expressing ACP - OR17-40 (filled circles,
black solid line) or ACP-OR17-40-GFP (filled squares, grey solid line) together
with Gαq. The EC50 of 108.0 ± 4.2µM for ACP - OR17-40 and of 90.7 ± 7.9 µM
for ACP - OR17-40 - GFP are comparable to the EC50 value of 98.7 ± 4.7µM
obtained for the wild-type receptor (open circles, black dashed line). Labelling of
the ACP - OR17-40 fusion construct with a saturating (5µM) concentration of
CoA-Cy5 does not impair the receptor activity (open triangles, grey dashed line).
Data, normalized to the highest response, are means ± SE of at least 3 independent
FLEXstation experiments.
4.3.2 Trafficking of OR17-40 in HEK293 Cells
We investigated the time course of OR17-40 biogenesis and translocation to the
plasma membrane of HEK293 cells either on individual cells using fluorescence
confocal microscopy, or on large cell populations using FACS analysis.
ACP - OR17-40 - GFP Biogenesis and Membrane Trafficking studied
by Confocal Microscopy — We found that the first GFP signals of the ACP -
OR17-40 - GFP double-tagged receptor were detectable in the endoplasmic retic-
ulum typically 4 h after the onset of transfection. The subcellular localization of
OR17-40 was confirmed by overlapping the fluorescence signal of the receptor with
a spectrally distinguishable enhanced cyan ER marker (Figure 4.2, A-C ), which
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was co-transfected together with the receptor construct. In parallel experiments,
we were able to overlap fluorescence images arising from the receptor with ECFP
targeted to the Golgi apparatus at ∼ 4 h 30 to 5 h after transfection (Figure 4.2,
D-F ). Interestingly, the receptor translocation from the ER to the Golgi appara-
tus was only seen in low expressing cells. At high expression levels, the receptors
accumulated in the ER and did not translocate to the plasma membrane (Figure
4.2, G-I ). This effect was still visible 12 or even 24 h after transfection.
7 to 8 h after the onset of transfection, the double-tagged receptor could be
detected at the cell surface of low expressing cells after labelling with CoA-Cy5
(Figure 4.2, J-L). The punctate pattern of Cy5 labelling is similar to the one
reported for other ORs stained with antibodies [82, 89], and suggests the aggre-
gation of the receptor into clusters. The reason for an aggregation of the OR
is not known, but, as homotypic OR interactions seem to mediate OSN axonal
targeting to specific glomeruli in the olfactory bulb [14, 116], OR clustering or
aggregation might arise from the natural tendency of the odorant receptors to self-
associate [67]. However, whether the clustering behavior of OR17-40 is influenced
by receptor-receptor interactions or by cell-specific factors should be investigated
by comparative studies of receptor expression in the natural cell background of
olfactory sensory neurons.
In a recent paper, Lu et al. reported that, when expressed in heterologous
cells, ORs are not selected for export from the ER and that ER-retained receptors
are degraded by the ubiquitin-proteasome system or are sequestered in ER aggre-
gates that are degraded by autophagy [67]. Furthermore, it was suggested that
intramolecular interactions affect OR trafficking [117]. Indeed, truncation prior
to the sixth transmembrane domain promoted the translocation of an odorant re-
ceptor to the plasma membrane of HEK293 cells, whereas co-expression of the
sixth and seventh transmembrane domains prevented cell surface expression of the
truncated protein [117].
Our results indicate that ORs are retained in the ER mainly in highly express-
ing cells, probably because of aggregation of the receptor due to over-expression.
Nevertheless, as shown by the co-localization of ACP - OR17-40 - GFP with a
Golgi marker, ORs exit the ER of low expressing cells and can be translocated
to the plasma membrane (Figure 4.2). Part of the receptors are thus efficiently
folded in these cells, suggesting that the poor plasma membrane targeting of odor-
ant receptors in heterologous cells is rather due to OR self-aggregation in the ER
than to receptor misfolding. However, even one or two days after transfection, part
of the GFP fluorescence could still be detected in the ER of low expressing cells.
This signal can arise either from newly synthesized receptors or from a fraction of
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Figure 4.2: Biogenesis and membrane trafficking of ACP - OR17-40 -
GFP. Confocal fluorescence micrographs showing HEK293 cells at different time
points after transfection with ACP - OR17-40 - GFP cDNA. 4 to 5 h after the
onset of transfection, the receptor is visible in the ER (A-C); about 30min later
it can be seen in the Golgi apparatus of low expressing cells (D-F), but not of
highly expressing cells (G-I, images taken 8 h after transfection). 7 to 8 h after
transfection, part of the receptors are inserted in the plasma membrane ( J-L). 1st
column, ACP - OR17-40 - GFP (GFP channel); 2nd column, ER (B) or Golgi
(E,H) marker, or CoA-Cy5 (K); 3rd column, transmission image of the same area,
with fluorescence images of the two first columns superimposed. Scale bar indicates
5 µm.
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the receptors which would be misfolded. This could be addressed by chemically
blocking new protein synthesis.
Studies on OR trafficking in odora cells supported a model comporting two
regulatory checkpoints [82]. The first checkpoint corresponds to the exit from the
ER, which is crucial in heterologous cells. Because ORs expressed in undifferenti-
ated odora cells are present in the Golgi but not at the plasma membrane, a second
checkpoint might occur at a post-Golgi compartment [82]. Our results do not indi-
cate that OR17-40 should be stuck at this second checkpoint, as the receptor was
visible at the cell surface a few hours after being present in the Golgi apparatus.
ACP - OR17-40 Expression Time Course — For a more quantitative analysis
of the receptor expression in large cell populations over time, we performed FACS
analysis on cells expressing the ACP - OR17-40 -GFP construct at different time
points after the onset of transfection. Labelling the cells with CoA-Cy5 allowed
the monitoring of the receptors reaching the plasma membrane, whereas recording
the GFP fluorescence intensity enabled the quantification of the total amount
of translated receptors. As shown in Figure 4.3, the total number of expressed
receptors reached a plateau ∼ 12 h after transfection. The time course of receptor
membrane insertion was delayed by 4 to 5 h.
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Figure 4.3: Time-lapse analysis of ACP - OR17-40 - GFP expression by
FACS. The total expression of receptors at different time points after transfection
onset was measured by monitoring the GFP fluorescence intensity (circles, solid
line), while the time course of receptors reaching the plasma membrane was fol-
lowed by recording the Cy5 fluorescence intensity (squares, dashed line). Data are
normalized to the fluorescence intensity after 25 h for each fluorophore.
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4.3.3 Constitutive Receptor Internalization
Cy5-labelled ACP - OR17-40 receptors exhibited a subcellular localization dis-
tributed between the plasma membrane and intracellular vesicles. As the ACP
technique only labels cell surface receptors, the intracellular fluorescent signals
must arise from internalized receptors. Although constitutive internalization in
absence of a ligand has been reported for several GPCRs, such as the human α1a-
adrenergic receptor [118], the M2 muscarinic receptor [119], the chemokine CXCRa
receptor [120], the CB1 cannabinoid receptor [121], the thrombin receptor [122],
and the thromboxane A2 receptor [123], to our knowledge, no indication of this
phenomenon has ever been provided for odorant receptors.
To verify that the internalization was not caused by the ACP labelling, we
performed the same experiment with another GPCR, the neurokinin 1 receptor
(NK1R), which was also fused to ACP. Cells expressing the Cy5-labelled NK1R
showed a strong fluorescence staining at the cell membrane, with almost no fluo-
rescence inside the cells.
Blocking the Clathrin-Mediated Internalization Pathway by Hypertonic
Sucrose — To characterize the pathway by which the constitutive internalization
of OR17-40 occurs, we tested the effect of hypertonic sucrose, which selectively
inhibits clathrin-mediated endocytosis by inducing abnormal clathrin polymeriza-
tion, thereby reducing the number of clathrin-coated pits [115]. The ACP - OR17-
40 fusion construct was labelled with CoA-CypHer, a pH-sensitive fluorescent dye,
which is non-fluorescent at neutral pH, and becomes highly fluorescent when it is
protonated [124]. This dye is a valuable tool for studying receptor internalization
into acidic vesicles [124]. When the cells expressing the ACP - OR17-40 fusion
construct were incubated in 0.45M sucrose 10min prior to and during labelling
with CoA-CypHer, the fluorescence of the cells was low and detectable at the cell
membrane. In contrast, in non-sucrose-treated control cells, the fluorescence in-
tensity was high and concentrated in vesicles that were moving below the plasma
membrane, indicating that the receptor was internalized (Figure 4.4). After su-
crose removal, apparition of fast moving intracellular vesicles in cells previously
incubated in hypertonic sucrose occurred in a time range of minutes.
The addition of 100µM or 200µM helional on cells expressing the ACP -
OR17-40 fusion construct and incubated in 0.45 M sucrose did not induce any
detectable receptor internalization, suggesting that both constitutive and agonist-
induced internalization occur along the clathrin-mediated pathway.
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Figure 4.4: The constitutive internalization of ACP - OR17-40 is blocked
by hypertonic sucrose. Fluorescence micrographs showing CypHer-labelled ACP
- OR17-40 fusion receptors after ACP labelling performed in the presence (A)
or absence (B) of 0.45M sucrose. Cells incubated with sucrose exhibit a faint
and rather homogenous membrane staining (A), while non-sucrose-treated cells
contain highly fluorescent mobile intracellular vesicles located just below the plasma
membrane (B). Scale bar indicates 5µm.
Co-Localization with Transferrin Receptor — In order to identify the or-
ganelles containing the internalized ACP - OR17-40 fusion receptor, we labelled
the cells with transferrin-alexa488 (Tf-alexa488). The transferrin receptor (TfR),
which is constitutively endocytosed to early endosomes and efficiently recycles to
the plasma membrane, is a commonly used marker for endosomes involved in pro-
tein sorting and recycling [118,125–127]. As shown in Figure 4.5, Cy5-labelled ORs
were mostly present in vesicles containing TfR after 30min to 1 h incubation at
37 oC, indicating that OR17-40 was localized in early or recycling endosomes after
that time. The overlapping of the two signals increased over time. Cells incubated
with 200µM helional for up to 1 h showed a similar distribution of intracellular
vesicles containing both OR and TfR (data not shown). A similar localization of
an odorant receptor in TfR-positive endosomes has previously been reported for
the U131 receptor in undifferentiated odora cells [82], indicating that constitutive
OR endocytosis is not specific to HEK293 cells.
Influence of Agonist or Antagonist Binding on Receptor Internaliza-
tion — The influence of agonist or antagonist binding on receptor internalization
was investigated on cells transiently expressing ACP - OR17-40 - GFP. 200µM
helional was added to the cells for 15min or for 1 h, whereas parallel cell sam-
ples were treated overnight with 300µM α-methyl-cinnamaldehyde (antagonist,
see Chapter 6). The subsequent labelling with CoA-Cy5 allowed the quantifica-
tion of cell surface receptors using FACS analysis. As shown in Figure 4.6, there
was no significant variation in the amount of labelled receptors after the different
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Figure 4.5: Co-localization of Cy5-labelled ACP - OR17-40 and trans-
ferrin receptor. Confocal fluorescence micrographs showing the localization of
transferrin receptor (green) and Cy5-labelled ACP - OR17-40 (red) in HEK293
cells. The co-localization of the two receptors is shown in yellow in the third col-
umn, which corresponds to the merging of the micrographs in the first two columns.
50µg/ml Tf-alexa488 was added to the cells during the ACP labelling, which was
performed at room temperature. Cells were then washed 3 times with D-PBS and
incubated at 37 oC for 10min (A), 30min (B) or 1 h (C). Scale bar indicates 5µm.
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treatments. Similar results were found for the human α1a-adrenergic receptor, for
which very little variation in the level of constitutive internalization was observed
upon addition of both an agonist or an inverse agonist [118]. As the receptors are
localized in recycling endosomes trafficking to and from the cell surface in absence
of ligand, it is likely that the surface receptor density is maintained constant by
recycling, even in presence of an agonist, so that the cells are not desensitized to
further ligand exposure [118, 126, 128]. In this respect, constitutive endocytosis
of the odorant receptor would help to maintain odor sensitivity over prolonged
receptor stimulation.
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Figure 4.6: Quantification of the amount of cell surface ORs before and
after ligand binding. The Cy5 fluorescence intensity was monitored for 35,000
HEK293 cells expressing the ACP - OR17-40 - GFP fusion construct and labelled
with CoA-Cy5 before (patterned) and after incubation with the agonist (black line),
or the antagonist (grey line).
Moreover, the constitutive internalization of OR17-40 is unlikely to be due to
the constitutive activation of the receptor or to exogeneous ligands present either in
the culture medium or in the air, as it is not blocked by antagonist treatment. This
suggests that an endocytic motif might be responsible for targeting the receptor
towards internalization. Studies on the thromboxane A2 receptor indicated that
a YX2−3φ (where X is any amino acid and φ is a bulky hydrophobic amino acid)
motif in the receptor carboxy-terminal tail was responsible for its constitutive
internalization [129]. Although this specific motif is not present in the C-terminal
part of OR17-40, it is not impossible that a different motif plays a similar role.
Altogether, these results also indicate that receptor internalization, which, in
the classical model of GPCR activation, is normally an agonist-dependent process,
can occur without G protein activation. The dissociation of receptor internalization
and G protein activation has already been shown for several other GPCRs, such
as a mutant of the µ-opioid receptor [130], the human cytomegalovirus-encoded
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seven-transmembrane receptor US28 [131], the metabotropic glutamate receptor
1a [127] or the complement factor 5a receptor [132], and suggests that GPCRs can
take many more states than usually believed [132].
4.4 Conclusions and Outlook
A functional double-tagged receptor construct enabled the monitoring of OR17-40
expression, trafficking, plasma membrane targeting and endocytosis in real time
in living cells. As heterologously expressed odorant receptors are often retained
in intracellular compartments, the combination of the intracellular GFP tag and
the extracellular fusion to ACP allowed the optical discrimination of cell surface
receptors from all translated receptors.
Using this strategy of multicolor labelling, which also involved subcellular
markers based on ECFP, we could show that part of the receptors were translo-
cated to the plasma membrane. The amount of these cell surface receptors was
higher in low expressing cells than in cells exhibiting high over-expression levels.
In highly expressing cells, the ORs did not exit the ER, probably because of re-
ceptor self-aggregation caused by over-expression. The use of a weak promoter
for OR expression in heterologous cells could thus lead to a better plasma mem-
brane localization of the receptor. However, first attempts in that direction were
not conclusive, as the expression of an OR17-40 - GFP fusion protein using the
ecdysone-inducible vector pIND (Invitrogen, Breda, NL) led to an unexpectedly
homogeneous subcellular localization: The receptor was even present in the nucleus
(data not shown).
As the ACP tag at the receptor N-terminus allowed the selective labelling
of cell surface receptors in living cells, we were able to follow the fate of OR17-
40 after its insertion in the plasma membrane. Interestingly, we could show that
OR17-40 undergoes constitutive internalization in the absence of an agonist. This
internalization process occurred along the clathrin-dependent pathway, and was
not influenced by agonist or antagonist binding. Uncoupling of receptor internal-
ization and G protein activation, two processes usually believed to result from
ligand binding, has already been shown for several GPCRs [127, 130–132], and
constitutive internalization is believed to be mediated by specific signals on the
carboxy-terminal tail of the receptors [122, 129, 131]. Moreover, since constitutive
endocytosis of several GPCRs seems to prevent receptor desensitization to further
exposure to an agonist [118,126,128], it is possible that OR constitutive internal-
ization, as demonstrated for the human OR17-40, helps to prolong odor sensitivity.
It would thus be interesting to investigate whether the constitutive endocytosis of
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odorant receptors also occurs in olfactory sensory neurons.
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Chapter 5
Lateral Diffusion of an Odorant
Receptor in HEK293 Cell
Membranes
5.1 Introduction
The lateral motion of integral membrane proteins plays an important role in many
biological phenomena by promoting for instance collisions of receptors and effec-
tors in the plasma membrane. For GPCRs in particular, there is evidence for a
non-random distribution of the receptors, G proteins, and effectors [133–135]. A
compartmentalization of the receptors and other partners could also explain the
rapidity and specificity of G protein-mediated signalling [136,137].
According to the fluid-mosaic model proposed by Singer and Jacobson more
than 30 years ago [138], the plasma membrane was until recently considered as
a two-dimensional solvent in which membrane proteins are homogeneously dis-
tributed and free to move. However, the plasma membrane of various mam-
malian cells is now known to be heterogeneous and to contain various types of
domains [139–143]. A first type of domain is referred to as lipid raft or cave-
ola. Lipid rafts are enriched in cholesterol, sphingolipids and glycosylphosphatidyl
inositol (GPI)-anchored proteins, and are thought to exist as liquid-ordered micro-
domains while the rest of the cell membrane would be liquid-disordered [144–146].
Reports about their size vary from 5-10 to 700 nm [144–147]. Very similar to
rafts, the caveola consists of a small flask-shaped plasma membrane invagination,
70-100 nm in diameter, that is coated with caveolin and contains the same lipid
components as rafts [143]. A second type of compartmentalization found in cell
membranes is caused by the membrane-associated cytoskeleton, which provides a
barrier to the free diffusion of membrane proteins due to the steric hindrance of
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the protein intracellular part [140, 148, 149]. Such domains can have a diameter
of 350-750 nm [146]. Due to the dynamical properties of the membrane skeleton,
proteins which are confined inside one compartment can eventually escape (hop)
to the next one [148]. Moreover, this type of confinement is not restricted to
molecules possessing an intracellular part [150]. For instance, the diffusion of a
lipid located in the outer leaflet of the plasma membrane and which was there-
fore not directly interacting with the membrane skeleton, was shown to also sense
the membrane compartmentalization [151]. It was proposed that, as many mem-
brane proteins are linked to the cytoskeleton, forming fences for molecules diffusing
in the plasma membrane, the membrane skeleton influences the lipid diffusional
behavior via transmembrane proteins immobilized to the cytoskeleton (”anchored-
protein picket” model) [151,152]. Finally, a third type of protein confinement might
arise from long-range attractions between membrane proteins. Such a confinement
would not involve the presence of physical fences and was recently proposed for
opioid receptors [153].
Compartmentalization and membrane heterogeneity can be revealed by mea-
suring the diffusion of molecules in the membrane. The classical way to measure
protein mobility in cell membranes is by fluorescence recovery after photobleaching
(FRAP). Briefly, dye molecules are bleached by means of a very intense illumina-
tion focused to a region of typically 1-10µm in diameter. The subsequent recovery
of the fluorescence signal due to the diffusion of unbleached molecules into the
bleached area is recorded. For most systems, an incomplete recovery of typically
25-80% [154] has been observed and interpreted within a two-component model
including a mobile and an immobile fraction of the species studied. However, be-
cause conventional FRAP gives ensemble-averaged recovery times, the behavior
of individual particles is masked. Furthermore, FRAP is not a feasible tool for
studying sparsely distributed receptors, because it requires a high density of labels
to generate a sufficient number of photons for proper photon statistics [155].
Recent advances in single-molecule microscopy (SMM) and spectroscopy (SMS)
at room temperature by laser-induced fluorescence offer new tools for observing
the movements of individual proteins or lipids in the cell membrane [154–156].
Such methods allow the examination of individual members of a heterogeneous
population and the identification and quantitative comparison of different sub-
populations. Single-particle tracking (SPT) studies have been carried out using
video-enhanced imaging systems and either nanometer-sized gold particles [157] or
highly fluorescent molecules [155].
Plasma membrane receptors are usually labelled using fluorescent ligands
or antibodies, or genetic fusions to autofluorescent proteins. However, fluorescent
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ligands doe not allow the study of unliganded receptors, antibodies are often larger
than the receptor itself and may interfere with its mobility and functionality, and
autofluorescent proteins are not very photostable and have excitation spectra in the
same range as autofluorescent cellular compounds. Here, we take advantage of the
newly developed ACP labelling technique, which enables the covalent attachment
of a long-wavelength fluorophore (Cy5), with high absorption cross-section, high
quantum yield and high photo-stability, to the human odorant receptor OR17-40.
In this chapter, we present the study of lateral diffusion of Cy5-labelled OR17-
40 in the plasma membrane of HEK293 cells. The principal objective was, first,
to characterize the movements of the receptor and identify a potential compart-
mentalization of the membrane, and, second, to monitor the receptor diffusional
behavior in presence of an agonist or antagonist.
5.2 Experimental procedures
5.2.1 Materials
CoA-Cy5 and AcpS were a kind gift from N. George and K. Johnsson (LIP-ISIC,
EPFL, CH). Helional, α-methyl-cinnamaldeyde and piperonal were kindly provided
by Dr C. Margot (Firmenich SA, Geneva, CH). Sucrose was purchased from Sigma
(Buchs, CH).
Cell culturing and preparation, as well as production of the cell line stably
expressing ACP - OR17-40 and Gαq were performed as described in Chapter 2.
The functionality of the ACP - OR17-40 fusion construct was shown in Chapter 4.
5.2.2 Experimental Set-Up
Experiments were performed on a modified epiluminescence wide-field microscope.
An intensified CCD camera allowed a sensitive detection of the light emitted by a
single fluorophore. A schematic view of the set-up is shown in Figure 5.1.
Cells grown on 8-well chambered coverglass slides were mounted on an epilu-
minescence wide-field microscope (Axiovert 200, Zeiss). Circularly polarized light
of a 632.8 nm HeNe laser (Coherent, Auburn, CA, USA) was directed by a dichroic
mirror (Q645LP, Chroma Corp., Rockingham, VT, USA) into a microscope objec-
tive (C-Apochromat 63x water-corrected, 1.2 NA, Zeiss) to illuminate a 22µm
diameter region of the sample. Fluorescence was collected by the same objective,
passed through an adequate filter (HQ710/120, Chroma Corp., Rockingham, VT,
USA), and imaged on an intensified CCD camera (I-Pentamax 512 EFT, Roper
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Scientific, USA). To minimize photobleaching, cells were only illuminated for 50ms
per image using a shutter (LS3T2, Vincent Associates, Rochester, USA).
5.2.3 Principle of Single-Molecule Microscopy
The observation of single molecules requires the use of fluorophores with high
quantum yield and high photostability, which emit light at a wavelength where
the background autofluorescence of the cell is low and where the detection effi-
ciency of the recording system is high. A dye that emits in the far red, like Cy5
(excitation: 650 nm; emission: 670 nm), is very well suited. The ACP labelling
technique enables the covalent attachment of only one Cy5 fluorophore per recep-
tor, thus avoiding artifactual diffusional behaviors caused by receptor cross-linking.
Moreover, receptors not properly inserted in the plasma membrane are not labelled
and therefore do not contribute to out-of-focus fluorescence. For single-molecule
detection, the concentration of labelled molecules has to be low enough that single
molecules can be separated. By varying the concentration of CoA-Cy5 substrate
added to the cells, it is possible to achieve an optimal amount of labelled recep-
tors to distinguish single molecules (5-20 labels per focal area). On the other
hand, non-specific binding of the label on the plasma membrane, which is a very
crucial obstacle for single-molecule tracking, is very low in our case because the
CoA-moiety is negatively charged.
The principle of single-molecule microscopy is illustrated in Figure 5.2A. The
wide-field epi-illumination together with the CCD camera allows the simultaneous
observation and localization of several single molecules.
A typical image of single receptor molecules is shown in Figure 5.2B. Each
receptor is labelled with only one fluorophore and the fluorescence is monitored over
time. After usually 2-50 images, the fluorophore is bleached, resulting in a one-step
decrease of fluorescence intensity (Figure 5.2C ). The question whether each bright
spot corresponds to a single receptor has to be addressed by three different criteria:
(i) The intensity is typical for single dye molecules, (ii) it exhibits blinking and/or
drops to background level in a single sharp step, and (iii) the size and shape of the
spot is diffraction limited.
5.2.4 Single-Molecule Experiments
Experiments were carried out on HEK293 cells stably expressing the ACP - OR17-
40 fusion construct together with Gαq. 24 to 36 h before the measurement, cells
were seeded in 8-well chambered coverglass slides and grown at 37oC in D-MEM
medium containing 10% FCS. On the day of measurement, cells were washed with
5.2 - Experimental procedures 55
S
h
u
tt
e
r
V
a
ri
a
b
le
 O
D
B
e
a
m
 e
x
p
a
n
d
e
r
C
o
n
d
e
n
s
e
r
D
ic
h
ro
ic
 m
ir
ro
r
M
ic
ro
s
c
o
p
e
 o
b
je
c
ti
v
e
S
a
m
p
le
O
c
u
la
r
C
C
D
 c
a
m
e
ra
F
il
te
r
E
x
c
it
a
ti
o
n
F
lu
o
re
s
c
e
n
c
e
H
e
-N
e
 L
a
s
e
r
P
o
la
ri
z
a
ti
o
n
 c
o
n
tr
o
ll
e
r
Figure 5.1: Schematic view of the single-molecule fluorescence imaging
microscope.
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Figure 5.2: Single-molecule imaging of OR17-40. (A) Principle of single-
molecule imaging. A 22µm spot is illuminated with laser light and the fluorescence
of single molecules is recorded with a high-sensitivity CCD camera. (B) Fluo-
rescence image of a single HEK293 cell containing Cy5-labelled ACP - OR17-40
receptors. Each diffraction-limited spot corresponds to a single receptor. The scale
bar indicates 5µm. (C) Fluorescence intensity recorded inside the marked ring in
B, for a series of images taken at 4Hz sampling frequency. The one-step photo-
bleaching is the signature of a single fluorophore.
D-PBS and labelled with Cy5 (50 or 500 nM CoA-Cy5, 1µM AcpS and 10mM
MgCl2 in D-PBS) for 30min at room temperature. Cells were then carefully washed
three to five times with D-PBS and mounted on a wide-field fluorescence micro-
scope. Series of 100 images were recorded at a sampling frequency of 4Hz with an
integration time of 50ms and an excitation light intensity of 0.5 kW/cm2. Images
were focused on the upper cell membrane and care was taken to measure on flat
cells. All measurements were performed at room temperature.
To investigate the effect of agonist binding on the receptor diffusional be-
havior, measurements were performed after the addition of 200µM helional. To
study the influence of an antagonist, cells were pre-incubated overnight in 300µM
α-methyl-cinnamaldehyde, and ACP labelling and measurements were performed
in presence of the antagonist. Control measurements were performed after the ad-
dition of 300µM piperonal. All three substances were freshly diluted in PBS from
a stock solution of 1M in DMSO, ensuring that the final DMSO concentration was
similar for the three compounds.
To block receptor endocytosis, cells were incubated in D-PBS containing
0.45M sucrose for 10 to 15min at 37oC prior to ACP labelling. Labelling and
measurements were performed in 0.45M sucrose.
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5.2.5 Data Evaluation
The diffusion of single receptors was analyzed with the help of a custom-made
computer program based on Igor Pro (WaveMetrics), that has been developed
in our laboratory to localize and track single fluorescent molecules, similarly to
[149,156,158]. The first step is the identification of real single molecules out of the
recorded image series. This is done by addressing the three above-cited criteria, i.e.
by the size of the fluorescent spot, its intensity and single-step photobleaching. The
computer program first locates bright spots, which clearly exceed the background
level. These candidates are then fitted with a two-dimensional Gaussian [158]
(Figure 5.3).
1 µm
A B C
Figure 5.3: Determination of the position of a single fluorophore. (A)
The spot of a single fluorescent molecule is diffraction-limited and appears therefore
spread over several pixels (pixel size: 225 nm). (B) The same image as surface
plot, showing the typical signal-to-noise ratio in the third dimension. (C) The
signal is fitted with a 2-D Gaussian to obtain the exact position of the fluorophore
(upper panel). Substracting the fitted Gaussian from the original image leaves the
background noise (lower panel).
The width of the peak in both dimensions and the signal-to-noise ratio are
taken as criteria to identify single receptor molecules. This allows the discrimi-
nation from artefacts caused by camera noise (too narrow) and from vesicles or
autofluorescence of the cell (too large). A successful fit gives the position of a
molecule with an accuracy much higher than the actual size corresponding to one
pixel. With ideal signal-to-noise ratios on solid substrates, an accuracy of 1 nm is
possible [159,160]. By measuring the position of CoA-Cy5 molecules immobilized
on a glass surface, a spatial accuracy of 34 nm was derived for our experimental
set-up. Although the positional accuracy is high, the optical resolution of the im-
age is only around 350 nm, and molecules have to be at least half the resolution
apart to be distinguishable.
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The positions of identified single molecules in individual images are linked
within an image series to obtain trajectories. This is done by calculating for all
images of a series the distances between all fitted molecules in image i to all fitted
molecules in image i + 1. If their concentration is low enough and the sampling
frequency high compared to their mobility, molecules can be tracked. The molecule
in image i+1 that is closest to a molecule in image i is considered to be the same
molecule if the distance between them is within a certain threshold value. Both
molecules are then added to the same track and evaluation is continued with image
i+2. Blinking, crossing of two molecules, and unsuccessful fits interrupt a track, so
that traces of single molecules need to be visually checked and interrupted tracks
manually linked. Furthermore, care should be taken that only traces which end
in a one-step photobleaching are evaluated. Once the traces are computed, square
displacements r2 are calculated between all points of a trace to yield maximal
statistics. The average r2 at each image interval, called mean square displacements
(MSD(tlag)), depend on the time interval between two images. The MSD for a given
time lag can be defined as the average over all independent pairs of points with that
time lag, and this averaging reduces the noise in an experimental trajectory [154].
The plot of MSD versus time lag can serve as a basis for the classification of
trajectories into different diffusion modes:
For free Brownian diffusion on a two-dimensional plane, the MSD increases
linearly with tlag:
MSD(tlag) = 4Dtlag, (5.1)
where D is the diffusion constant.
If the diffusion is confined within certain barriers, the diffusion inside the
compartment is free for short tlag, corresponding to MSDs much smaller than the
compartment size, and, at larger tlag, the MSD does not exceed the compartment
size but reaches a constant value. Such behavior is described for square compart-
ments by [149]
MSD(tlag) =
L2
3
·
[
1− exp
(
− 12Dtlag
L2
)]
, (5.2)
where L is the averaged length of the domain, and D the diffusion constant.
For immobile molecules, MSDs stay constant over time.
In addition, directed diffusion might occur, when molecules are transported
or influenced by other forces. In this case, the MSD increases more than linearly
with tlag:
MSD(tlag) = v
2t2, (5.3)
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where v is the drift velocity.
Finally, anomalous subdiffusion, which occurs in presence of obstacles or
traps in the cell membrane, leads to
MSD(tlag) = Γt
α
lag, (5.4)
with α < 1.
Cumulative distribution function — Traces of individual molecules are often
too short for the determination of MSDs(tlag) with sufficient accuracy. Therefore
the data of individual molecules are combined to improve statistics, but by doing
this, differences between all diffusion modes are averaged out. To detect any
heterogeneity in the diffusion of different populations, MSDs can be evaluated
following the method proposed by Schu¨tz and Schmidt [146,156]: The cumulative
probability distribution P to find a molecule after a certain time tlag inside a radius
r is plotted versus r2.
For a single population of molecules, this distribution is described by a single
exponential:
P (r2, tlag) = 1− exp
(
− r
2
MSD(tlag)
)
(5.5)
If two populations of molecules are present with different diffusion modes or
diffusion constants, P reads
P (r2, tlag) = 1−
[
f ·exp
(
− r
2
MSDfast(tlag)
)
+(1−f)·exp
(
− r
2
MSDslow(tlag)
)]
, (5.6)
where f is the fraction of fast diffusing molecules and MSDfast and MSDslow are
the mean square displacements for the fast and slow moving fractions, respectively.
5.3 Results and Discussion
5.3.1 Diffusion of OR17-40 in HEK293 Cell Membranes
The diffusion of Cy5-labelled ACP - OR17-40 receptors was monitored in HEK293
cell membranes. Typical traces, recorded at 4 Hz sampling frequency, were up
to 60 images long (Figure 5.4). Data from 230 molecules measured on about 40
different cells were evaluated.
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Figure 5.4: Trace length distribution of Cy5-labelled ACP - OR17-40
before photobleaching. Traces were recorded at 4Hz sampling frequency, with
50ms illumination time. The average trace length is around 17 frames, or 4 sec-
onds.
Mean square displacements of individual receptors — The goal of SMM
analysis is to sort trajectories into various diffusion modes and to characterize the
diffusion by giving quantities such as the diffusion coefficient, drift velocity, con-
finement size, or anomalous diffusion exponent. This task is made difficult in case
of limited duration or time resolution of the trajectories: The longer the trajec-
tory of a single molecule, the more reliable its classification into one of the different
modes or the detection of a change in its diffusion mode during the measurement.
There is no universal method for SMM data analysis. A first method, devel-
oped by Kusumi and colleagues [149], consists in the determination of the micro-
scopic diffusion coefficient D for each molecule, by fitting with a straight line its
MSDs at time lags 2δt, 3δt, and 4δt. The values of D determined by this method
are referred to as D2-4, or ”initial diffusion coefficient”. D2-4 is convenient because
it can be determined independently of the diffusion mode. In order to sort trajec-
tories into different modes of motion, deviations of the individual MSD(tlag) from a
straight line with a slope 4D2-4 are calculated: Positive and negative variations ac-
count for directed and restricted diffusion, respectively [149]. However, one needs
long traces in order to classify them according to this method.
A second method is based on the construction of a probability distribution
P (r2, tlag) of many individual molecules in order to improve statistics [156]. This
is useful when the traces of the single molecules are short, but the information
about individuals is lost. Although this method still allows the distinction between
two different subpopulations of molecules (see Data Analysis), and gives the mean
diffusion coefficient D and the mean compartment size L for each subpopulation, it
cannot discriminate classes when the population is more heterogeneous. Moreover,
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it is strictly valid only for free diffusion.
Before choosing a method of analysis, we examined the trajectories of in-
dividual receptors, and calculated the experimental mean square displacement
MSD(tlag) independently for each molecule. Examples of such MSD(tlag) are illus-
trated in Figure 5.5. Typically, four classes of molecules were observed: molecules
undergoing free Brownian diffusion (1), diffusing confined inside large (2), or small
(3,4) compartments, and immobile molecules (5).
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Figure 5.5: Diffusion modes of odorant receptors. (A) The position of
Cy5-labelled ACP - OR17-40 was evaluated from 2D Gaussian fits for each image
of a series taken at 4Hz sampling frequency. Trajectories are shown on top of
a representative fluorescence image of the respective tracked molecule (pixel size:
225 nm). (B) Mean square displacement time courses (broken lines) of the tra-
jectories depicted in A. Solid lines represent the fit of the MSD(tlag) according to
the analytical formula for free Brownian diffusion (1) and confined diffusion (2-
5). Note that the vertical scale is different for the different MSDs. Four different
classes of molecules were observed: freely diffusing molecules (1), molecules diffus-
ing inside a large (2) or a small (3, 4) compartment, and immobile molecules (5).
Confined molecules can be either fast confined (3), or slow confined (2,4).
Classification of the receptor trajectories — The observation of the trajec-
tories revealed that, although few receptors diffused freely in HEK293 cell mem-
branes, the movements of most ORs appeared confined within domains of various
sizes. The apparent confinement might arise from the presence of microdomains
and/or from inter-protein interactions or obstacles in the plasma membrane. In
the latter case, the receptors undergo anomalous diffusion and their movements
can be described by Equation 5.4, whereas the movements of receptors diffusing
confined inside a domain can be described by Equation 5.2. At this stage of the
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analysis, it is difficult to decide for one model over the other. We thus fitted the
individual MSD(tlag) curves with both Equation 5.4 and Equation 5.2. In general,
qualitatively, the MSD(tlag) curves were better fitted by the model for confined
diffusion than by the one for anomalous diffusion. Also, Equation 5.4 is intrisically
more difficult to fit. For these reasons, the analysis was pursued with the model
for confined diffusion.
Fitting the MSD(tlag) curves with Equation 5.2 yields two important para-
meters: the apparent domain size L, and the microscopic diffusion coefficient D,
which characterizes the movement of the molecule in its immediate neighborhood.
It should be pointed out that the fit with Equation 5.2 did not converge for all
MSD(tlag) curves: For some fast molecules, the first experimental points necessary
for determining D were non-reliable. In this case, only the domain size L was
extracted.
A scatter plot of the fitted apparent domain sizes and diffusion coefficients for
Cy5-labelled ACP - OR17-40, as well as the histograms of these two parameters,
are shown in Figure 5.6. For more clarity on the graphs and to distinguish the
fast molecules from the others, the values of their diffusion coefficient was set to
0.5µm2/s. Similarly, molecules with a very large diffusion range (more than 3
µm) had their L arbitrarily set to 3µm. If we disregard the points for which D
and L were arbitrarily set, the logD versus logL values are distributed around
a line of slope 2, indicating that D ∝ L2. This dependence of the microscopic
diffusion coefficient on the domain size was already noticed by Daumas et al. for
another GPCR, the µ-opioid receptor, and was assumed to arise from protein-
protein interactions [161].
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Figure 5.6: Microscopic diffusion coefficients and apparent domain sizes.
(A) Log-log plot of the apparent domain size L versus the diffusion coefficient
D determined for each trajectory from the MSD(tlag) fit with Equation 5.2. (B)
Distribution of the diffusion coefficient D. The peak at D = 0.5µm2/s corresponds
to the fast molecules. (C) Distribution of the apparent domain size L. The peak
at L = 3µm corresponds to the molecules with a very large diffusion range.
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D is distributed over several orders of magnitude: 1.6 × 10−3 ≤ D ≤ 4.2 ×
10−1 µm2/s. Diffusion coefficients around 1 x 10−1 µm2/s measured by FRAP have
been reported for several GPCRs, such as the β2-adrenergic receptor [162], the neu-
rokinin NK2 receptor [163], or the gonadotropin-releasing hormone receptor [164].
The majority of odorant receptors however have a slower microscopic diffusion co-
efficient, which could result from the binding of the receptor to the cytoskeleton or
to clathrin-coated structures. Further discussion of this issue will be given later.
The distribution of the apparent compartment sizes is also broad: 5×10−2 ≤
L ≤ 3 µm. If we disregard the molecules for which L was set to 3µm, the his-
togram shows a continuous distribution of L, with a maximum at ∼ 300 nm and
two shoulders, the first one at ∼ 200 nm and the second one at ∼ 500 nm. As
the comparison of this distribution with the distributions of the domain sizes ob-
tained for the liganded receptor shows a significant difference in the population
corresponding to the first shoulder (see below), we assumed that this shoulder cor-
responds to the population diffusing inside small domains, which increases upon
ligand binding. Molecules diffusing more than 1 µm can be considered as freely
diffusing molecules, as a large domain size could simply arise from the non-planar
geometry of the cell and the molecule going out of focus. Moreover, by measuring
the noise on immobile molecules, as well as by comparing this distribution with the
distributions of the confinement sizes for the liganded receptor, we could assume
that molecules diffusing inside apparent confinement sizes smaller than 0.14µm are
immobile. We thus classified the trajectories according to the apparent domain size
determined from their MSD(tlag) fit.
Four classes of molecules were separated: (i) immobile molecules, with 0 <
L < 0.14µm; (ii) small-confined molecules, with 0.14 ≤ L < 0.25µm; (iii) large-
confined molecules, with 0.25 ≤ L ≤ 1µm; and (iv) freely diffusing molecules,
with L > 1µm. The sorting procedure is summarized in Figure 5.8. It should be
noted that it was sometimes very difficult to decide if a molecule was immobile or
confined inside a small domain by visual inspection. This is reflected by the large
overlap of the population of immobile molecules and of small-confined molecules
(Figure 5.6C ). The different fractions of the molecules classified according to these
criteria are illustrated in Figure 5.7.
9% of Cy5-labelled ACP - OR17-40 are immobile. 12% are freely diffusing
in the cell membrane. 30% diffuse inside small domains of 195 ± 10 nm, while
49% diffuse inside larger domains of 390 ± 40 nm. The movements of the odorant
receptor inside these compartments are random. The molecules stayed usually
confined inside one domain during the whole observation time and hopping from
one compartment to another was very rarely seen.
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Figure 5.7: Classification of the receptor trajectories into four diffusion
modes. The OR trajectories were separated in four classes according to the value
of the apparent domain size L calculated from their MSD(tlag) fit with Equation
5.2: (i) the immobile fraction corresponds to L < 0.14µm; (ii) the small-confined
fraction corresponds to 0.14 ≤ L < 0.25µm; (iii) the large-confined fraction cor-
responds to 0.25 ≤ L ≤ 1µm; and (iv) the free Brownian fraction corresponds to
L > 1µm.
Cumulative probability distribution analysis — The analysis using the cu-
mulative probability distribution allows the distinction between one or two sub-
populations of molecules in an ensemble. To determine whether the four classes
of receptors that were separated contained sub-classes, and also to determine if
they are really Brownian, confined or anomalous, cumulative probability distri-
bution functions (PDFs) were calculated for each time lag within one class and
fitted either mono- or double-exponentially (Equations 5.5, 5.6). The PDFs of
the immobile, small-confined, and large-confined molecules were better fitted with
a mono-exponential function, indicating that each of these classes represented
only one population. In contrast, the freely diffusing molecules could be sep-
arated into two subpopulations diffusing in a Brownian mode (Figure 5.9): 70
± 16% of the freely diffusing receptors diffused fast, with a diffusion coefficient
Dfast = 0.019±0.002µm2/s, whereas the second fraction diffused more slowly, with
Dslow = 0.0019± 0.0004µm2/s (Figure 5.10, A-C ).
The MSD(tlag) curves derived from the mono-exponential fit of the PDF for
the immobile, small-confined, and large-confined molecules, could be fitted with
Equation 5.2, that describes confined motion, yielding the diffusion coefficients and
the domain sizes listed in Table 5.1. However, the small-confined fraction could
be described as well by the model for anomalous diffusion, with an anomalous
coefficient α = 0.141 ± 0.003, suggesting that the apparent confinement could
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Figure 5.8: Procedure used for sorting the OR trajectories. (A) D and
L were determined from the MSD(tlag) fits. (B) The trajectories were classified
according to L.
result from protein-protein interactions.
The very small diffusion coefficient calculated for the immobile fraction con-
firms that these molecules are indeed immobile. Moreover, the domain sizes for
the small-confined and large-confined fractions are similar to the ones determined
by fitting the individual MSD(tlag) curves. The cumulative probability distribu-
tion analysis confirms then the results obtained by the analysis of the individual
trajectories.
D (µm2/s) L (µm/s)
large-confined 0.0066 ± 0.0006 0.36 ± 0.02
small-confined 0.0082 ± 0.0002 0.195 ± 0.002
immobile 0.000132 ± 0.000008 0.136 ± 0.012
Table 5.1: Diffusion coefficients and confinement sizes for the large-
confined, small-confined, and immobile receptors.
The plasma membrane of HEK293 cells thus exhibits two types of compart-
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Figure 5.9: Cumulative distribution function of the freely diffusing and
small-confined OR17-40 receptors. (A) The P(r2, 1s) of the free fraction is
well described with Equation 5.6 (solid line), indicating that the freely diffusing re-
ceptors can be sub-divided into two populations. In contrast, the fit with Equation
5.5 was not successful (broken line). (B) The P(r2, 1s) of the small-confined frac-
tion can be described with a mono-exponential function (Equation 5.5), indicating
that this fraction represents only one population.
mentalization: a first one of size L = 195 ± 10 nm and a second one of size L = 390
± 40 nm. Similar domain sizes have been found for the confinement of the neu-
rokinin NK2 receptor in HEK293 cells [163]: The NK2R was shown to diffuse inside
domains of radius = 420 ± 80 nm in absence of ligand, and inside domains of radius
= 170 ± 50 nm when bound to neurokinin A (NKA). The larger domains could
either arise from the presence of a membrane-skeleton/cytoskeleton fence struc-
ture [148,165,166] or from long-range protein interactions [153], whereas the smaller
domains are likely to correspond to precursors of clathrin-coated pits [42, 163].
Indeed, as discussed in Chapter 4, OR17-40 is constitutively internalizing when
expressed in HEK293 cells. Co-localization of the receptor with the transferrin
receptor, a marker of clathrin-coated pits, as well as disruption of receptor en-
docytosis by hypertonic sucrose indicated that this internalization occurred along
the clathrin-dependent pathway. Several GPCRs, such as the β2-adrenergic recep-
tor [167] or the thyrotropin-releasing hormone receptor [168], have been shown to
accumulate in previously formed clathrin-coated domains upon activation, rather
than nucleating new coated pits, as was previously believed. It is also believed
that the receptors are targeted inside pre-pits that are still flat and which invagi-
nate following clathrin polymerization [169]. Cezanne et al. estimated that, since
clathrin-coated pits have a radius of 75-100 nm, the radius of the corresponding
flat domains should measure between 150 and 200 nm [163], which corresponds to
the small domains of confinement found for OR17-40.
The receptors belonging to the immobile fraction are probably in course of
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Figure 5.10: Cumulative probability distribution analysis. (A-C) The
freely diffusing receptors could be separated into two subpopulations diffusing in
a Brownian mode: A fraction of 0.70 ± 0.16 diffused fast (A), with a diffusion
coefficient Dfast = 0.019 ± 0.002µm2/s (B). The second fraction was diffusing
more slowly, with Dslow = 0.0019 ± 0.0004µm2/s (C). (D) The large-confined
fraction of receptors diffused with D = 0.0066 ± 0.0006µm2/s inside a domain
of size L = 0.36 ± 0.02µm. (E) The small-confined fraction diffused with D =
0.0082 ± 0.0002µm2/s inside a domain of size L = 0.195 ± 0.002µm. (F) The
immobile molecules diffused very slowly (D = 0.000132 ± 0.000008µm2/s) inside
a very small domain (L = 0.136± 0.012µm).
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internalization, which is very slow at the experimental temperature [170]. Indeed,
receptors located inside clathrin-coated pits are thought to be tightly packed and
immobile [148], and, since the formation of coated pits repeatedly occurs at definite
sites of the plasma membrane, coated pits themselves are believed to be attached
to the membrane skeleton [171]. Moreover, immobile and small-confined molecules
often photobleached in a multi-step manner, as shown in Figure 5.11, indicating
that several receptors were located very closely one to another, below the resolution
limit. These receptors are probably located inside clathrin-coated pits, waiting for
internalization.
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Figure 5.11: Multistep photobleaching. (A) Fluorescence image of Cy5-
labelled ORs stably expressed in HEK293 cells. In the region indicated by the arrow,
the receptors are organized in clusters. Scale bar indicates 5µm. (B) Fluorescence
intensity recorded inside the marked ring in image A. Multi-step photobleaching
indicates that several receptors are located inside this ring.
It should be noted that during the examination of individual trajectories, we
did not observe any molecule undergoing directed motion, for example towards the
clathrin-coated pits. This suggests that the receptors are trapped at the coated
pits following random diffusion, and are not targeted towards the pits by lipid flow
or by transport by the cytoskeleton [148].
5.3.2 Lateral Diffusion of ACP - OR17-40 with Bound Ag-
onist or Antagonist
To investigate the effect of ligand binding on the lateral diffusion of OR17-40, mea-
surements were performed after addition of 200µM helional (agonist) or 300µM
α-methyl-cinnamaldehyde (antagonist, see Chapter 6). As a control, the diffu-
sion of Cy5-labelled ACP - OR17-40 was also monitored after addition of 300µM
piperonal, a compound structurally similar to the agonist (Figure 5.12E ) but that
does not bind to the receptor. The trajectories of about 130 molecules for each
condition were evaluated. Analysis was performed in the same manner as for the
unliganded receptor.
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The log-log plots of D versus L for all three compounds and the histograms
for the microscopic diffusion coefficients and for the apparent domain sizes are
shown in Figure 5.12.
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Figure 5.12: Mobility analysis of liganded ORs. (A) Log-log plot of the diffu-
sion coefficient D against the apparent domain size L for the unliganded receptor
(open circles), the receptor bound to an agonist (full squares), and the receptor
bound to an antagonist (full triangles). (B) Classification of the trajectories into
four diffusion modes, according to the domain size determined from their MSD(tlag)
fit, for the different conditions. (C and D) Distribution of the diffusion coefficient
D (C) and of the apparent domain size L (D). (E) Chemical structures of the ag-
onist helional, the antagonist α-methyl-cinnamaldehyde, and the control substance
piperonal.
Although the distribution of the diffusion coefficients after addition of he-
lional, α-methyl-cinnamaldehyde or piperonal does not differ greatly from the one
obtained for the unliganded receptor (Figure 5.12C ), the distribution of the do-
main sizes changes significantly depending on the added compound. As shown
in Figure 5.12B, the fraction of small-confined molecules increases from 30% to
50% upon agonist addition and to 51% in presence of the antagonist, whereas the
fraction of large-confined molecules decreases from 49% to 31% for the agonist
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and to 24% for the antagonist. These two fractions stay constant upon addition
of the control substance piperonal (28% for the small-confined fraction and 48%
for the large-confined fraction). The sizes of the two types of compartments are
listed in Table 5.2.
Lsmall (nm) Llarge (nm)
no ligand 195 ± 10 390 ± 40
agonist 190 ± 5 370 ± 40
antagonist 190 ± 5 400 ± 60
control 195 ± 10 420 ± 40
Table 5.2: Domain sizes for the liganded and unliganded receptor. Data
are means ± 95% confidence interval of the small and large compartment sizes
determined from the fit of the MSD(tlag) curves.
If we consider that the small domains of confinement correspond to precursors
of clathrin-coated pits, the fact that the small-confined fraction increases upon
agonist binding is expected, as activated receptors are recruited to clathrin-coated
pits and subsequently internalized. A similar restriction of receptor diffusion was
found for the NK1R [172] and the NK2R [163] after the addition of an agonist.
Why this also occurs upon antagonist addition is not clear. The increase in the
small-confined fraction is due to specific ligand binding, as the control substance
piperonal does not alter the diffusional behavior of the receptor. An antagonist
causing internalization was also found for the cholecystokinin receptor [173]. It was
postulated that the conformational change in the receptor induced by or stabilized
by the antagonist results in the unveiling of a domain that could promote receptor
internalization [173]. Similarly, our results suggest that the presence of a ligand
inside the receptor binding pocket is sufficient to promote the targeting of the
receptor to precursors of clathrin-coated pits, even without receptor activation.
We can thus postulate that both agonists and antagonists modulate the continuous
recycling of the odorant receptor.
5.3.3 Lateral Diffusion of ACP - OR17-40 in Hypertonic
Sucrose
In order to block the constitutive endocytosis of the receptor, cells stably expressing
ACP - OR17-40 and Gαq were incubated in D-PBS containing 0.45M sucrose
for 10 to 15 min prior to and during labelling with CoA-Cy5. The diffusion of
the Cy5-labelled receptors was monitored in 0.45M sucrose. As shown in Figure
5.13, hypertonic sucrose was found to induce an immobilization of the receptors:
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The immobile fraction increased to 30% and the small-confined fraction to 50%,
whereas the large-confined fraction decreased to 17%. The immobilization was
reversed upon sucrose removal. The sizes of the two types of compartments are
listed in Table 5.3.
0.001 0.01 0.1 1
D (µm
2
/s) D (µm
2
/s)
0.1
1
L
 (
µ
m
)
0.4
0.2
0.0p
ro
b
a
b
il
it
y
 d
e
n
s
it
y
10
-4
10
-3
10
-2
10
-1
 in PBS
sucrose
sucrose
0.3
0.2
0.1
0.0p
ro
b
a
b
il
it
y
 d
e
n
s
it
y
0.1 1
L (µm)
 in PBS
sucrose
sucrose
60
40
20
0
n
u
m
b
e
r 
o
f 
m
o
le
c
u
le
s
 (
%
)
in PBS + sucrose - sucrose
 immobile
 small conf.
 large conf.
 free
A
B
C
D
Figure 5.13: OR mobility analysis when the constitutive internalization
is blocked. (A) Log-log plot of the diffusion coefficient D against the apparent
domain size L for the receptor when the cells are in PBS (open circles), when the
cells are incubated in 0.45M sucrose (closed squares), and after sucrose removal
(closed triangles). (B) Classification of the trajectories into four diffusion modes,
according to the domain size determined from their MSD(tlag) fit, for the different
conditions. (C and D) Distribution of the diffusion coefficient D (C) and of the
apparent domain size L (D).
Lsmall (nm) Llarge (nm)
in PBS 195 ± 10 390 ± 40
in 0.45M sucrose 180 ± 10 440 ± 100
after sucrose removal 185 ± 20 440 ± 70
Table 5.3: Domain sizes for the receptor in PBS and in hypertonic
sucrose. Data are means ± 95% confidence interval of the small and large com-
partment sizes determined from the fit of the MSD(tlag) curves.
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As already discussed, ORs are probably targeted to flat precursors of clathrin-
coated pits [163, 169]. Since clathrin polymerization is blocked by hypertonic su-
crose, the pre-pits do not invaginate and the receptors do not internalize. It is
likely that, in order to maintain a constant cell surface receptor density, the re-
cycling of the receptors from the endosomes is diminished. There would then be
a higher density of receptors immobilized inside precursors of clathrin-coated pits
than of free receptors. Furthermore, as hypertonic sucrose induces shrinkage of
the cells, it is possible that the interactions with the cytoskeleton are tightened,
thus accounting for the increased immobilization of the receptor.
5.4 Conclusions and Outlook
In conclusion, we monitored the lateral diffusion of the human odorant receptor
OR17-40 in HEK293 cell membranes. While few (12%) receptors were undergoing
normal Brownian diffusion, the movements of most ORs were confined inside two
types of domains. A first type of compartment, of size L = 390 ± 40 nm, seems to
arise from the presence of the membrane-skeleton/cytoskeleton fence structure or
from long-range inter-protein interactions, while the smaller compartments (L =
195 ± 10 nm) are likely to be precursors of clathrin-coated pits [163].
In agreement with the fact that OR17-40 receptors undergo constitutive en-
docytosis, as discussed in Chapter 4, 30% of the unliganded receptors belong to the
small-confined fraction. This fraction increases upon addition of both an agonist
(51%) or an antagonist (50%), whereas the large-confined fraction decreases (49%
to 31% for the agonist and to 24% for the antagonist), suggesting that the binding
of a ligand can promote the targeting of the odorant receptor to clathrin-coated
pre-pits, even without activating the receptor.
Hypertonic sucrose, which blocks the constitutive endocytosis of the recep-
tor, also induces an increase in the small-confined fraction, probably by modifying
the equilibrium between the receptors inside clathrin-coated pre-pits and the free
receptors. Moreover, the fraction of immobile receptors increases. This immobi-
lization might arise from anchoring of the receptors by clathrin and/or by the actin
cytoskeleton [163, 171]. This could be addressed in future experiments by using
fluorescent clathrin [171] or by modulating actin dynamics by the over-expression
of actin-binding proteins [163].
Chapter 6
Characterization of an Extended
Ligand Repertoire of OR17-40
using Calcium Imaging
6.1 Introduction
The chemical interaction of volatile molecules with odorant receptors is the primary
step in odor perception and is a central focus of current research activities for
unravelling the molecular basis of olfaction, its selectivity, and sensitivity. The
pairing of odorant receptors with their ligands, so far achieved for only a limited
number of receptors, pointed to either a broad tuning or a high OR selectivity for
few or single odorants [74,75,79,174,175].
In this chapter, we analyzed odorant structure-response relationships on
OR17-40, which has been shown to respond to one single compound (helional)
out of a mixture of 100 odorants, but not to a closely related molecule (piper-
onal) [75], and investigated molecular determinants critical for the recognition of
the ligand by OR17-40. In order to test a collection of chemically modified deriv-
atives of helional for their ability to activate the receptor, a large-scale functional
assay allowing efficient screenings of compounds was developed. This assay is based
on the optical detection of intracellular calcium release upon odorant stimulation,
which can be achieved by stably expressing the human odorant receptor OR17-40
in HEK293 cells together with the promiscuous G protein Gαq.
Based on the observation that cells with high OR expression levels have
a low cell surface targeting, and that the carboxy-terminal fusion of OR17-40
to the enhanced green fluorescent protein (EGFP) retains full receptor activity,
we then explored the use of fluorescence-activated cell sorting (FACS) for the
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separation of low OR17-40 - GFP expressing cells, resulting in the enrichment of
cells exhibiting OR surface expression and an improved efficiency of OR-mediated
calcium signalling.
6.2 Experimental Procedures
6.2.1 Materials
Cytochalasin B was from Sigma (Buchs, CH); 1-palmitoyl-2-oleoyl-sn-glycero-3-
(phosphor-rac-(1-glycerol)) (POPG) was from Avanti Polar Lipids (Alabaster, Al,
USA); N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-phospho-
ethanolamine, triethylammonium salt (fluorescein DHPE) was from Molecular
Probes (Eugene, OR, USA).
Odorants were kindly provided by Dr C. Margot (Firmenich SA, Geneva,
CH).
6.2.2 Flow Cytometry and Sterile Cell Sorting
Cell samples were diluted in DMEM to concentrations between 1-5x106 cells per
ml. Flow cytometry was performed using a Becton Dickinson FACS Vantage sorter
(excitation: 488 nm / emission: 525 nm). Gates were set to exclude cellular de-
bris and to sort cells in two defined fractions of high and low GFP fluorescence
intensities. Analysis was performed using the Cell Quest program from BD Sci-
ences. Collected cells were resuspended in DMEM containing 10% FCS, puromycin
(20µg/ml) and hygromycin (200µg/ml), and antibiotics selection was continued
for 1 to 4 weeks in 25 cm2 culture flasks in a 37 oC/5% CO2 incubator.
6.2.3 Receptor Quantification
Cell surface concentrations of odorant receptors were estimated by GFP fluores-
cence intensity measurements on native vesicles derived from the plasma mem-
brane of cells expressing OR17-40 - GFP. Native vesicles were produced by in-
cubating the cells with 10µg/ml cytochalasin B for 10 to 15min at 37 oC. Cell
bodies were separated from native vesicles by centrifugation at 500 rpm for 5min.
Vesicles were collected at 2,000 rpm for 20min and resuspended in 1ml PBS.
The GFP fluorescence intensity (excitation: 488 nm / emission: 510 nm) was
measured on selected plasma membrane regions of the vesicles using the Zeiss
LSM510 software, and compared with those of unilamellar vesicles comprising a
defined amount of fluorescein-labelled lipids. The lipid mixture was composed of
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1-palmitoyl-2-oleoyl-sn-glycero-3- (phosphor-rac-(1-glycerol)) (POPG) mixed with
0.05-5 per mille N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt (fluorescein DHPE).
Cell culture, transfection and stable cell lines selection, as well as immuno-
cytochemistry and Ca2+ - FLEX assay were performed as described in Chapter
2.
6.3 Results and Discussion
6.3.1 Functional Expression of an OR17-40 - GFP Fusion
Construct
The insertion of odorant receptors in the plasma membrane is important for their
proper configuration and biological function. We monitored the subcellular local-
ization of OR17-40 in two ways. First, EGFP fused at the receptor C-terminus
allowed the subcellular detection of all intracellular and plasma membrane recep-
tors; second, the N-terminal fusion of a c-myc epitope provided a tool to selectively
visualize OR17-40 receptors on the cell surface (Figure 6.1B). As already discussed
in Chapters 3 and 4, the receptor translocation to the cell membrane was better in
faint green cells, reflecting a lower OR expression level. Furthermore, mainly these
weak fluorescent cells evoked helional-mediated calcium responses, as monitored
by in situ calcium imaging using laser-scanning confocal microscopy.
To quantitatively compare the activation of the two receptor proteins by dif-
ferent ligands, HEK293 cell lines stably expressing either the wild-type OR17-40
or the carboxy-terminal fusion of OR17-40 to EGFP were established by antibiotic
selection for 6 to 8 weeks. The stable co-expression of Gαq allowed the functional
coupling of OR17-40 activation to the inositol 1,4,5-triphosphate (IP3) pathway,
resulting in the opening of intracellular Ca2+ ion stores, which can be detected
by monitoring the fluorescence intensity of calcium-sensitive indicator dyes. The
selection of cell lines stably expressing both the odorant receptor and the G pro-
tein allowed for efficient functional screenings in microtiter plates using the high-
throughput FLEXstation instrument.
The activation of OR17-40 - GFP by its cognate ligand was first confirmed
by the obtention of helional dose-dependent calcium responses. The resulting EC50
value of 114.4 ± 8.6µM was comparable to that determined on the wild-type re-
ceptor (98.7 ± 4.7µM) (Figure 6.1C ), indicating that the human odorant receptor
OR17-40 fused to GFP retained its full activity.
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Figure 6.1: Subcellular localization and functional characterization of
OR17-40 fused to EGFP. (A) Schematic view of the membrane topology of
OR17-40 - GFP showing the position of the inserted EGFP at the C-terminus and
of the c-myc epitope at the N-terminus, after the rhodopsin membrane import se-
quence. (B) Multi-channel confocal micrograph of a representative HEK293 cell
population transiently expressing c-Myc-OR17-40-EGFP labelled with the mono-
clonal anti-c-myc, Cy3 conjugate antibody. Upper right-hand image (Ex. 488 nm
/ Em. 505-530 nm) shows cell-to-cell differences of c-Myc-OR17-40-EGFP fluo-
rescence intensities. Upper left-hand image (Ex. 543 nm / Em 560 nm) shows the
immuno-localization of Cy3-labelled c-Myc-OR17-40-EGFP in plasma membranes.
Lower image shows an overlay of the green, red, and transmission channel indicat-
ing that weakly expressing cells (low EGFP fluorescence intensities) exhibit a better
translocation of c-Myc-OR17-40-EGFP to the cell surface than strongly expressing
cells, as reflected by higher Cy3 fluorescence signals on plasma membranes. Scale
bar is 10 µm. (C) Concentration-response relation of helional on Ca2+ release in
HEK293 cells stably expressing OR17-40 and Gαq (circles, solid line) or OR17-40
- GFP and Gαq (squares, broken line). Data, normalized to the highest response,
are means ± S.E. of at least 3 independent FLEXstation experiments.
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6.3.2 Determination of an Extended Ligand Repertoire of
OR17-40
Based on the high ligand selectivity of OR17-40 [75], we were interested in ana-
lyzing molecular features of helional essential for its recognition by the receptor.
In committing this study, we followed two strategies. The first one was based on
measurements performed with the HEK293 cell line stably co-expressing the wild-
type OR17-40 and Gαq. The other strategy involved the use of the OR17-40 - GFP
fusion construct, which exhibited the same ligand specificity as the wild-type recep-
tor (Table 6.1), but allowed for a more rapid selection of odorant-responsive cells
based on fluorescence-activated cell sorting as described below. We tested odorant
compounds structurally related to helional for their ability to elicit intracellular
calcium responses (Figure 6.2). Seven out of 23 tested compounds activated OR17-
40 in a dose-dependent manner. Among these odorants, lilial was the most potent
one. We found that agonists lacking a molecular group in the para position on the
aromatic ring, such as α-methyl-hydrocinnamaldehyde, methyl-phenyl-pentanal,
and trifernal, were less effective (Table 6.1). None of the tested odorants evoked
non-specific calcium responses on control cells expressing only the Gαq protein
without the receptor.
Our results suggest that the aldehyde group of the ligand is essential, as
its replacement by other chemical groups (alcohol, acetate, ketone, etc.) yielded
odorant molecules that did not bind to the receptor. Furthermore, the length of
the carbon chain between the aldehyde and the aromatic ring is of importance,
since piperonal and vanillin, which have a shorter carbon chain, failed to induce a
calcium response. Removing the methyl group also impaired receptor activation,
as shown for hydrocinnamaldehyde and bourgeonal. However, shifting it from the
α to the β position on the carbon chain (methyl-phenylpentanal, trifernal) was
tolerated. The insertion of a double bond in the case of α-methyl-cinnamaldehyde
effectively decreased the ability of the ligand to activate the receptor. Analogous
findings on the human testicular receptor OR17-4 [176] revealed inactivation of
receptor-specific ligands by introducing additional double bonds in the carbon
chain connecting the aldehyde group to an aromatic ring. Finally, the modification
of functional groups at the aromatic ring structure did not significantly influence
the interaction with OR17-40.
Since previous reports on a number of ORs have demonstrated that slight
modifications of activating ligands could give rise to antagonistic effects [175–178],
we tested whether the non-activating compounds of our collection had inhibitory
properties. We found that pre-incubation of cells expressing OR17-40 with three
different odorants (α-methyl-cinnamaldehyde, hydrocinnamaldehyde, and bour-
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Figure 6.2: Odorant specificity of wild-type OR17-40. (A) Dose-response
curves of OR17-40 agonists: helional (closed circles); lilial (closed squares); foli-
aver (closed triangles); cyclosal (closed inverted triangles); trifernal (open circles);
aldehyde TPM (open squares); methyl-phenylpentanal (open triangles); and methyl-
hydrocinnamaldehyde (open inverted triangles). HEK293 cell populations stably ex-
pressing OR17-40 and Gαq were stimulated with increasing concentrations of the in-
dicated odorants and the fluorescence intensity of a calcium-sensitive indicator dye
was measured in a microplate reader. Data, normalized to the highest response for
each odorant, are means ± S.E. of at least 3 independent experiments. (B) Inhi-
bition of the helional-induced Ca2+ ion response by α-methyl-cinnamaldehyde (cir-
cles); hydrocinnamaldehyde (squares); and bourgeonal (inverted triangles). Cin-
namyl alcohol (triangles) is shown as a control substance. Increasing concentra-
tions of the antagonists were added 100 s prior to the addition of 200µM helional.
At the end of each measurement, ATP (100µM) was applied to verify cell viabil-
ity. Data, normalized to the helional response in absence of antagonist, are means
± S.E. of 2 independent experiments. (C) Structural comparison of the different
substances used in this study. The cognate ligand helional is shown in the middle.
The activating substances are depicted in the light grey area and the non-activating
ones in the dark grey area. Antagonists are separated by white lines in the upper
right-hand corner.
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geonal) blocked the activation of the receptor by helional in a dose-dependent
manner (IC50: α-methyl-cinnamaldehyde: 154.7± 17.5µM; hydrocinnamaldehyde:
341 ± 33.2µM; bourgeonal: 133.1 ± 7.3µM). The molecular structures of these
compounds indicate that removing the methyl group or inserting an additional
double bond at the α position of the propanal chain leads to antagonistic effects.
All antagonists were tested at concentrations that did not affect the cell viabil-
ity (for bourgeonal, concentrations higher that 200µM were harmful for the cells,
since a subsequent stimulation by ATP evoked a reduced or even no intracellular
calcium response).
Odorant OR17-40 [µM] OR17-40 - GFP [µM]
helional 98.7 ± 4.7 114.4 ± 8.6
lilial 63.9 ± 2.0 124.1 ± 7.1
foliaver 96.7 ± 4.1 145.4 ± 10.1
cyclosal 112.3 ± 16.0 142.9 ± 6.2
aldehyde TPM 113.3 ± 4.2 139.5 ± 3.4
methyl-hydro-
cinnamaldehyde 163.2 ± 10.0 168.0 ± 12.3
methyl-phenyl-
pentanal 157.0 ± 7.5 158.5 ± 25.8
trifernal 154.6 ± 17.4 120.3 ± 6.6
Table 6.1: Ligand activity profiles for wild-type OR17-40 and for OR17-
40 - GFP. EC50 values are means ± S.E. of at least 3 independent experiments.
6.3.3 Enrichment of Odorant-Responsive Cells
Based on our observation that mainly HEK293 cells with low GFP fluorescence
intensities exhibited functionally active OR17-40 - GFP at the plasma membrane
which induced sufficiently strong calcium ion signalling amplitudes, we explored
the possibility of selecting those cells from a transiently transfected HEK293 cell
population.
We used fluorescence-activated cell sorting (FACS) to separate cells express-
ing OR17-40 - GFP and Gαq in two fractions of defined GFP fluorescence inten-
sities (Figure 6.3A), which were individually analyzed for their ability to elicit
calcium signals in response to helional. Ligand-induced intracellular calcium ion
responses were significantly stronger in the cell fraction exhibiting a low GFP flu-
orescence intensity than in the strong fluorescent one (Figure 6.3C ). In support
of this finding, we obtained in a parallel selection of 20 transfected cell samples
only one stable OR17-40 - GFP cell line exhibiting overall low and relatively ho-
mogenous GFP fluorescence intensities (Figure 6.3D). A flow cytometry analysis
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Figure 6.3: Flow cytometry and cell sorting of OR17-40 - GFP. (A)
EGFP fluorescence intensity distribution of HEK293 cell populations transiently
expressing OR17-40 - GFP and Gαq. The cells were sorted in two fractions of low
and high intensity. (B) EGFP fluorescence intensity distribution of a helional-
responsive clone stably expressing OR17-40 - GFP and Gαq. The cells were sorted
in two fractions of low and high intensity. (C) Concentration-response relation of
helional on Ca2+ release in the cell fractions sorted in A and B: cell line stably
expressing OR17-40 - GFP (black circles); low fluorescent cell fraction transiently
expressing OR17-40 - GFP (grey squares); high fluorescent cell fraction transiently
expressing OR17-40 - GFP (light grey triangles). (D) Confocal fluorescence micro-
graph of the low fluorescent cell fraction stably expressing OR17-40 - GFP. Scale
bar indicates 20 µm. (E) Confocal fluorescence micrograph of native vesicles de-
rived from cells in D. Scale bar indicates 2 µm. (F) Distribution of OR17-40 -
GFP in the membrane of native vesicles. The receptor density was determined
by comparing the GFP intensity in the vesicle membranes to the intensity in the
membrane of artificial vesicles containing known concentrations of fluorescein.
of this clone indicated a fluorescence intensity similar to the odorant-responsive
fraction derived from transiently transfected cells (Figure 6.3C ). We conclude that
an efficient translocation of OR17-40 to the cell surface and, in turn, a strong
odorant-evoked calcium signalling, correlates with defined low levels of intracellu-
lar receptor biosynthesis.
We therefore determined the cell surface density of OR17-40 in the low flu-
orescent cell fraction. For the selective analysis of GFP fluorescence intensity sig-
nals in plasma membranes, we produced native vesicles from cells stably expressing
OR17-40 - GFP by chemical treatment with cytochalasin B (Figure 6.3E ). Such
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native vesicles were shown to retain the orientation and functionality of surface re-
ceptors [179]. By comparison with reference fluorescent lipid membranes of giant
unilamellar vesicles, we could estimate a receptor density distribution between 0
(not detectable) and 300 receptors per square micrometer. This maximal value cor-
responds to roughly 130,000 receptors per cell, considering a HEK293 cell surface
of 450µm2 [180]. However, the majority of the cells had less than 100 receptors
per square micrometer, or less than 45,000 receptors per cell (Figure 6.3F ).
6.4 Conclusions
A large-scale functional assay based on the optical read-out of odorant responses
by calcium imaging was developed. By screening a library comprising 23 chemical
derivatives of the cognate ligand helional, we could determine the molecular de-
terminants necessary for OR17-40 binding and/or activation: An aldehyde group
connected to an aromatic ring via a carbon chain of 3-5 carbons appears to be
essential for binding to the receptor, while a methyl group in α or β position
is necessary for its activation. Moreover, an additional double bond within the
carbon chain also leads to antagonistic effects.
Since the carboxy-terminal fusion of OR17-40 to EGFP retained its full ac-
tivity and since low expressing cells exhibit a better plasma membrane localization
of the odorant receptor, we used FACS sorting to enrich odorant-responsive cells
out of a population with variable OR expression levels. In the separated low fluo-
rescent fraction, calcium responses were obtained in up to 80% of the cells, which
significantly enhanced the signal-to-noise ratio essential for high-throughput mea-
surements in fluorescence plate readers. Compared to classical antibiotic selection
procedures, the FACS selection was significantly less time-consuming and allowed
for rapid screenings of odorant molecules within 4-6 days after transfection.
82 6 - Characterization of a Ligand Repertoire for OR17-40
Chapter 7
Towards a Chip-Based Screening
of Odorant Molecules: Calcium
Imaging in Cell-Derived Vesicles
7.1 Introduction
Odorant molecules, which can influence personal behaviors in many respects, like
the choice of food, personal hygiene, household products, and fashion, represent
a market of large economic impact. Important industrial branches such as per-
fume producers and food industry are concerned with the production of odorant
substances of constant quality, as well as with the development of new odorous
compounds. In this context, there is a need for objective and efficient screening of
odorant molecules.
As described in Chapter 6, heterologous expression and functional imaging
of recombinant ORs in HEK293 cells has been achieved by forcing the receptors
to induce an intracellular Ca2+ ion release through the over-expression of promis-
cuous G proteins that couple to the DAG/IP3 signalling pathway [74, 75, 79, 80].
This strategy of translating OR activation into an optically detectable signal can
lead to large-scale functional screenings. However, odorant molecule analysis is
complicated by the combinatorial recognition principles of odor coding [66, 181],
as one molecule usually leads to the activation of a set of ORs. It is therefore
reasonable to test odors on a collection of odorant receptors to discover patterns
of activation which can be used as ”fingerprints” for a given odorant.
In this chapter, we present a novel strategy allowing a substantial minia-
turization of assays for odorant molecule detection, opening new ways for parallel
screenings in an array format. We take advantage of micrometer or submicrometer-
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sized mammalian cell-derived native vesicles containing ORs in their membrane
and molecular components of the signalling cascade in their lumen. Native vesicles
have been shown to be the smallest autonomous containers capable of perform-
ing cellular signalling reactions under physiological conditions [179]. They can be
prepared in large quantities, frozen and stored for weeks without losing their func-
tional integrity, and are thus extremely useful for the investigation of signalling
reactions in a parallel format [179].
As a proof of principle, we develop this assay with two ORs, the human
helional receptor OR17-40 and the nematode ODR-10 receptor, which specifically
responds to diacetyl [68, 69, 80]. Both receptors can be functionally expressed in
HEK293 cells and coupled to the phosphoinositol pathway, allowing an optical
read-out of receptor activation by calcium imaging [75,80].
7.2 Experimental Procedures
7.2.1 Materials
ODR-10 cDNA was a kind gift from H. Hatt (Ruhr-Universita¨t, Bochum, D). The
Venus variant of GFP was kindly provided by A. Miyawaki (Saitama, Japan) [182].
The pECFP-N1 plasmid was from Clontech (Palo Alto, CA, USA). Gαq - CFP was
a kind gift from B. Meyer (LCPPM-ISIC, EPFL, CH).
Cytochalasin B was from Sigma (Buchs, CH). FuraRed was from Molecular
Probes (Eugene, OR, USA).
Helional was kindly provided by Dr C. Margot (Firmenich SA, Geneva, CH).
Diacetyl was purchased at Sigma (Buchs, CH).
7.2.2 Fluorescence Labelling of Odorant Receptors with
Spectrally Distinguishable GFP Variants
pOR17-40 - YFP was obtained by replacing the GFP coding sequence of pEAK8::
OR17-40 - GFP by YFP. The YFP coding sequence was first amplified from Venus
by PCR using the following primers: YFP-fo: 5’- CGC GGA TCC ATG GTG AGC
AAG GGC GAG GAG CTG -3’; YFP-rev: 5’- CGC GAT CGA TGC GGC CGC TTA CTT
GTA CAG CTC GTC CAT GCC -3’; and the resulting 750 bp BamHI - NotI fragment
was subcloned into pBS::OR17-40 - GFP (see Chapter 3) digested with BamHI
and NotI. OR17-40 - YFP was cut out with EcoRV and NotI and subcloned into
pEAK8.
Cloning of the ODR-10 - CFP fusion construct was obtained by the following
strategy: For a better plasma membrane localization, the 20 first amino acids of
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the bovine rhodopsin [74] followed by a NdeI site were added at the N-terminus of
ODR-10 by PCR using the following primers: ODR-10-fo: 5’- TCT GAT ATC GC
ACC ATG AAC GGG ACC GAG GGC CCA AAC TTC TAC GTG CCT TTC TCC AAC AAG
ACG GGC GTG GTG CAT ATG TCG GGA GAA TTG TGG ATT ACC CTA GTT GAC ACA
GCG G -3’; ODR-10-rev: 5’- CGC GAT CGA TGC GGC CGC TCA CGT CGG AAC TT
G AGA CAA ATT GGC -3’; and the resulting 1.1 kb EcoRV - NotI fragment was sub-
cloned both into the cloning vector pBluescript II KS+ and into the mammalian
expression vector pEAK8, yielding pBS::ODR-10 and pEAK8::ODR-10. The stop
codon of ODR-10 was replaced by a BamHI site using site-directed mutagenesis
on pBS::ODR-10. CFP was amplified by PCR from pECFP-N1 using the fol-
lowing primers: CFP-fo: 5’- CGC GGA TCC ATG GTG AGC AAG GGC GAG GAG CTG
-3’; CFP-rev: 5’- CGC GAT CGA TGC GGC CGC TTA CTT GTA CAG CTC GTC CAT
GCC -3’; and the resulting 750 bp BamHI - NotI fragment was subcloned into
pBS::ODR-10. ODR-10 - CFP was cut out with EcoRV and NotI and subcloned
into pEAK8.
All plasmids were verified by restriction analysis and DNA sequencing.
7.2.3 Single-Cell Calcium Imaging
HEK293 cells exponentially growing in 6-well plates were transfected with pOR17-
40 - YFP or pODR-10 - CFP together with pGαq DNA using the calcium phosphate
precipitation method [76]. Twenty-four hours after transfection, cells expressing
the blue or the yellow receptor construct were shortly trypsinized, mixed in the
same tube, centrifuged for 4min at 1,200 rpm, resuspended in DMEM containing
2.2% FCS, and seeded on 25mm glass cover slides placed in 6-well plates. After
incubation for 24 h at 37 oC in a humidified 5% CO2 atmosphere, cells were loaded
with 5µM FuraRed-AM in serum-free DMEM for 30min at 37 oC. The dye loading
medium was then exchanged against DMEM containing 10% FCS and the cells
were placed in the incubator for another 30min in order to allow for cleavage
of the ester. Odorant-mediated calcium ion responses were recorded using laser-
scanning confocal microscopy. Detection and distinction of YFP and CFP, and of
the FuraRed dye, was achieved by appropriate filter sets (see Chapter 2) using a
multitracking mode.
7.2.4 Native Vesicle Production
Native vesicles were produced from cells stably expressing the OR17-40 - GFP
fusion construct together with Gαq by a 10-20min incubation at 37
oC with cy-
tochalasin B (10µg/ml). Cells were first separated from vesicles by centrifugation
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at 500 rpm for 5min in an Eppendorf centrifuge. Vesicles were then collected by
centrifugation at 2000 rpm for 20min and resuspended in D-PBS.
7.2.5 Calcium Imaging of Odor Responses in Native Vesi-
cles
Cells were loaded at 37 oC for 30min with 5µM FuraRed-AM in serum-free DMEM
and were then washed and incubated in DMEM containing 10% FCS for 30min.
Subsequently, cells were treated with cytochalasin B as described above.
Vesicles containing FuraRed were transferred to 8-well chambered coverglass
slides pre-coated with 0.1mg/l poly-L-Lysine to ensure electrostatic binding of
the vesicles to the glass surface, and were investigated by confocal fluorescence
microscopy. The excitation was at 488 nm (Ar+ laser); 505-530 nm band-pass or
560 nm long pass filters were used to image the GFP-tagged receptor or FuraRed,
respectively. Individual responses to 100µM helional were recorded for 120 s.
7.3 Results and Discussion
7.3.1 Functionality of the Fluorescent Odorant Receptors
For the direct visualization and optical discrimination of two different odorant
receptors inside living cells, and, subsequently, to be able to address odorant-
mediated responses in vesicles to specific receptors, we genetically fused Venus to
the human OR17-40, and CFP to the nematode ODR-10. Figure 7.1 shows that
the two receptors can be distinguished in mixed cell cultures of OR17-40 - YFP and
ODR10 - CFP expressing cells. Ligand-specific receptor activation was observed
by laser-scanning confocal microscopy. Helional specifically activated OR17-40 -
expressing cells and diacetyl ODR-10 - expressing cells, indicating the functional
expression of these receptors. Cells highly expressing any of the two receptor
constructs did not respond upon addition of the odorants, probably because of an
inefficient membrane trafficking of the receptors, as already discussed in Chapters
4 and 6.
7.3.2 Receptor and G Proteins are Present in Native Vesi-
cles
Native vesicles derived from the plasma membrane of cells expressing OR17-40
fused to GFP were tested for their ability to be activated by the OR17-40-specific
agonist helional. As shown in Figure 7.2A, vesicles produced using cytochalasin
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Figure 7.1: Ligand-specific activation of two differently labelled odor-
ant receptors. (A and B) Confocal fluorescence micrographs of HEK293 cells
transiently expressing OR17-40 - YFP (A) or ODR-10 - CFP (B) together with
Gαq. (C) Transmission image of the same area with the fluorescence micrographs
A and B superimposed. Scale bar indicates 20µm. (D) Simultaneous recordings in
response to helional (100µM) and diacetyl (100µM) measured by laser-scanning
confocal microscopy using FuraRed as a calcium indicator dye. The OR17-40 -
YFP fusion construct (solid line, response corresponding to cell #1 on image C)
responds specifically to helional and the ODR-10 - CFP fusion construct (dashed
line, response corresponding to cell #2 on image C) specifically to diacetyl. Arrows
indicate the time points of odorant stimulation.
B contained the receptor in the vesicle membrane. To allow the detection of
odorant receptor activation by calcium signalling, it is necessary that the native
vesicles contain G proteins and the other molecular components of the transduction
cascade. The presence of G proteins in native vesicles could be confirmed by
treating cells expressing Gαq - CFP with cytochalasin B (Figure 7.2B).
7.3.3 Odorant-Induced Calcium Signalling in Native Vesi-
cles
Native vesicles were prepared from HEK293 cells transiently or stably expressing
OR17-40 - GFP together with the promiscuous Gαq protein. The number of native
vesicles containing the odorant receptor was rather low (5 to 10%) when vesicles
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A B
Figure 7.2: Localization of the odorant receptor and of the G protein
in native vesicles. Fluorescence confocal micrographs showing OR17-40 - GFP
fusion construct (A) and Gαq fused to CFP (B) inside cell-derived native vesicles.
Scale bar indicates 2µm.
were prepared from transiently transfected cells. In contrast, when derived from
a cell line stably expressing OR17-40 - GFP together with Gαq (see Chapter 6),
almost all vesicles contained the OR. For this reason, we performed calcium imag-
ing experiments on native vesicles prepared from this stable cell line, which was
loaded with FuraRed before treatment with cytochalasin B.
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Figure 7.3: Imaging odor responses in cell-derived vesicles. (A) Ligand-
induced calcium release inside native vesicles derived from cells stably expressing
the OR17-40 - GFP fusion construct together with Gαq. Vesicles were loaded with
the calcium ion indicator dye Fura-Red and stimulated with helional. Changes in
fluorescence intensities were recorded for 100 s using laser-scanning confocal mi-
croscopy. The addition of 100µM helional (arrow) induced a transient calcium in-
crease inside vesicles of different diameters: 2.26µm (circles); 2.76µm (squares);
2.99µm (diamonds); 3.57µm (triangles); and 5.05µm (inverted triangles). (B)
Size distribution of the vesicles which responded to 100µM helional addition.
Upon helional addition, a transient calcium increase was monitored inside
native vesicles (Figure 7.3A), indicating that the orientation and functional activ-
ity of odorant receptors and of cytosolic proteins were preserved. However, only
vesicles of a diameter larger than 2µm responded upon ligand application (Figure
7.4 - Conclusions and Outlook 89
7.3B), probably because the endoplasmic reticulum, which is needed as a cellular
ion store, is only present in bigger vesicles. This limitation could be overcome by
using the natural olfactory signalling pathway found in OSNs: In these cells, the
binding of an odorant molecule to the receptor induces an increase in the intracel-
lular concentration of cAMP, which is mediated by an olfactory-specific G protein
subunit, Gαolf. cAMP binds to cyclic nucleotide-gated (CNG) ion channels, lead-
ing to an influx of Na+ and Ca2+ from the outside. In HEK293 cells co-expressing
an OR and Gαolf, ligand binding can induce cAMP signalling [79, 89]. Moreover,
calcium imaging allowed the monitoring of odorant-induced Ca2+ influx through
CNG channels in HeLa cells stably co-expressing an odorant receptor, Gαolf and
a CNG channel [175]. It should thus be possible to perform calcium imaging on
native vesicles derived from HEK293 cells stably co-expressing these three com-
ponents (an OR, Gαolf and the CNG channel). This strategy should allow the
monitoring of OR activation in nanometer-sized vesicles.
7.4 Conclusions and Outlook
Native vesicles were produced from HEK293 cells co-expressing OR17-40 - GFP
and the G protein Gαq. The OR, as well as the other components of the signal
transduction machinery were present inside vesicles in their correct configuration.
We provided evidence for the localization of a fluorescently labelled Gαq at the
inner side of the vesicle membrane.
As a proof of principle, we could show that native vesicles are capable of re-
sponding to exogenously added odorant compounds by transient calcium signalling,
thus allowing the miniaturization of functional assays for the screening of odor-
ant molecules in small volumes. Monitoring odorant receptor activation in native
vesicles represents an important finding which opens new ways for assay miniatur-
ization and the development of micro-arrays for the screening of odorant molecules:
Collections of native vesicles representing large libraries of different odorant recep-
tors can be modified by proper tags at the vesicle surface (biotin, polyhistidine,
oligonucleotides, lectins, antigens, etc.) provided by labelled lipids [183, 184] or
proteins [98, 100, 185] and enabling the formation of microarrays of vesicles by
self-assembly on complementary micropatterned sensor surfaces [186,187].
As a first step towards such parallel screenings, we have labelled two OR
subtypes, the human helional receptor OR17-40 and the nematode diacetyl recep-
tor ODR-10 with spectrally distinguishable GFP variants, and demonstrated that
these fusion proteins retained full receptor activity. We propose the fluorescent
labelling of the ORs in order to address odorant-mediated simultaneous responses
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in vesicles to a specific OR subtype. This strategy allows screenings on different
ORs. It is however obvious that labelling with available GFP variants will deliver
only a limited set of optically distinguishable ORs. Post-translational in vivo la-
belling methods, where a fluorescent label is covalently or non-covalently attached
to a fusion tag or fusion protein [97–102], should increase the diversity and allow
the specific and distinguishable labelling of a set of 10-20 OR subtypes. Such a
collection might already be sufficient to obtain reliable ”fingerprints” of calcium
signalling profiles for a specific odorant molecule.
Chapter 8
Summary and Outlook
The discovery fourteen years ago of a multigene family encoding odorant recep-
tors [1] provided a molecular basis for initiating studies on the sensitivity and
selectivity of these receptors, and on biochemical processes involved in olfaction.
However, due to the great difficulty of functionally expressing odorant receptors
in the plasma membrane of heterologous cells, only little progress has so far been
achieved in matching odorant molecules to specific receptors and in establishing
efficient screenings of large compound collections.
In order to analyze the problem of inefficient OR surface expression in more
detail, we focused on the sequential stages in the life cycle of the human odorant re-
ceptor OR17-40, analyzing its intracellular biosynthesis, its membrane trafficking,
and its internalization back into the cytoplasm. For this purpose, OR17-40 was
modified by different tags, which enabled the direct visualization of the receptor
expression and subcellular localization in living cells. Using multi-color labelling
of OR17-40 and subcellular markers, we could show that high receptor expression
led to the accumulation of the receptor in the endoplasmic reticulum of HEK293
cells, probably because of receptor self-aggregation caused by over-expression. Co-
expression of various accessory proteins did not enhance its cell surface expression.
The use of a double-tagged receptor construct, which allowed the discrimination
of membrane-inserted receptors from the whole population of translated receptors,
revealed that the translocation of the receptor to the plasma membrane was better
in low expressing cells.
The selective labelling of membrane-inserted receptors and their observation
by confocal microscopy in real time interestingly revealed the constitutive inter-
nalization of OR17-40 in HEK293 cells. Co-localization of the receptor with the
transferrin receptor, a marker of clathrin-coated pits, as well as disruption of re-
ceptor endocytosis by hypertonic sucrose indicated that the internalization process
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occurred along the clathrin-dependent pathway. Moreover, the level of receptor
endocytosis was not influenced by agonist or antagonist binding, suggesting that
activation and internalization of OR17-40 are two independent processes.
In agreement with this finding, we could show that, in absence of ligand, ∼
30% of the cell surface receptors were confined inside small domains of 195± 10 nm,
which probably correspond to precursors of clathrin-coated pits. While 12% of
the receptors seemed to diffuse freely in the plasma membrane, 49% were diffusing
within domains of 390 ± 40 nm. This fraction decreased and the proportion of
receptors confined inside the smaller domains increased upon binding of an agonist
or an antagonist, suggesting that both can direct OR17-40 towards clathrin-coated
pre-pits, even without receptor activation.
In order to analyze the structural properties of odorant molecules essential
for OR17-40 binding and/or activation, we developed an efficient functional assay
based on the optical read-out of odorant responses by calcium imaging. By testing a
collection of chemical derivatives of the cognate ligand helional, we could determine
that an aldehyde group connected to an aromatic ring via a carbon chain of 3-5
carbons seems essential for binding to the receptor, while a methyl group in α or
β position appears to be necessary for its activation. Moreover, the addition of a
double bond in the carbon side chain leads to antagonistic effects.
As a first step towards more efficient odorant screenings, we developed a
miniaturized assay based on cell-derived native vesicles containing different odor-
ant receptors. By labelling with spectral variants of GFP, we could demonstrate
that native vesicles contained the OR in their membrane, and the molecular com-
ponents necessary for a functional response in their lumen. Furthermore, native
vesicles containing OR17-40 fused to GFP together with the G protein Gαq re-
sponded to helional by a transient calcium increase, indicating the preservation of
functional activity of the receptor. The micro- or sub-micrometer size of native
vesicles makes them suitable for assays in micro-array format, allowing the paral-
lel and simultaneous screening of many odorant receptors, and yielding a specific
pattern of activation which could be used as a fingerprint for a given odor molecule.
Glossary
ACP Acyl carrier protein
AcpS Phosphopantetheine transferase from E. coli
AOB Accessory olfactory bulb
ATP Adenosine triphosphate
β2-AR β2-adrenergic receptor
βARK-1, βARK-1 β-adrenergic receptor kinase 1, 2
βarr1, βarr2 β-arrestin 1, 2
Ca2+ Calcium ion
cAMP Cyclic adenosine monophosphate
cDNA Coding DNA
C. elegans Caenorhabditis elegans
CHO cells Chinese hamster ovary cells
CNG channel Cyclic nucleotide-gated channel
CoA Co-enzyme A
C-terminus Carboxy-terminus
DAG Diacylglycerol
DMEM Dulbecco’s modified Eagle medium
DNA Desoxyribonucleotide acid
D-PBS Dulbecco’s phosphate buffered saline
E. coli Escherichia coli
ECFP Enhanced cyan fluorescent protein
EGFP Enhanced green fluorescent protein
ER Endoplasmic reticulum
EYFP Enhanced yellow fluorescent protein
FACS Fluorescence-activated cell sorting
FCS Fetal calf serum
FRAP Fluorescence recovery after photobleaching
GABA Gamma aminobutyric acid
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GDP Guanosine diphosphate
GFP Green fluorescent protein
GPCR G protein-coupled receptor
GPI Glycosylphosphatidylinositol
G protein Heterotrimeric GTP-binding protein
GRK G protein-coupled receptor kinase
GTP Guanosine triphosphate
HEK293 cells Human embryonic kidney cells
IP3 Inositol triphosphate
MOB Main olfactory bulb
MOE Main olfactory epithelium
MSD Mean square displacement
NK1R Neurokinin 1 receptor
NK2R Neurokinin 2 receptor
N-terminus Amino-terminus
OBP Odorant binding protein
OR Odorant receptor
ORF Open reading frame
ORK Olfactory receptor kinase
OSN Olfactory sensory neuron
PBS Phosphate buffered saline
PCR Polymerase chain reaction
PDF Probability distribution function
PKA Protein kinase A
PKC Protein kinase C
PLCβ Phospholipase C type β
PPTase Phosphopantetheine transferase
REEP1 Receptor expression enhancing protein 1
RGS Regulator of G-protein signalling
RNA Ribonucleotide acid
rpm Round per minute
RTP1, RTP2 Receptor transporting protein 1, 2
SD Standard deviation
SE Standard error
SMM Single-molecules microscopy
SMS Single-molecule spectroscopy
SPT Single-particle tracking
T1R, T2R, T3R Taste 1,2,3 receptor
Tf Transferrin
TfR Transferrin receptor
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Mathematical Symbols
D Diffusion coefficient
Dmicro Microscopic diffusion coefficient
L Domain length
r2 Square displacement
tlag Time lag
EC50 Molar concentration of an agonist that produces 50%
of the maximal possible effect of that agonist
IC50 Molar concentration of an antagonist required for 50%
inhibition of the response evoked by an agonist
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